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ABSTRACT 
 
 
Goulding, Ann Marie. Ph.D., Purdue University, August 2010.  Biochemical 
Applications of DsRed-Monomer Utilizing Fluorescence and Metal-Binding Affinity.  
Major Professor:  Sapna K. Deo. 
 
 
The discovery and isolation of naturally occurring fluorescent proteins, FPs, have 
provided much needed tools for molecular and cellular level studies.  Specifically the 
cloning of green fluorescent protein, GFP, revolutionized the field of biotechnology and 
biochemical research.  Recently, a red fluorescent protein, DsRed, isolated from the 
Discosoma coral has further expanded the pallet of available fluorescent tools.  DsRed 
shares only 23 % amino acid sequence homology with GFP, however the X-ray crystal 
structures of the two proteins are nearly identical.  DsRed has been subjected to a number 
of mutagenesis studies, which have been found to offer improved physical and spectral 
characteristics.  One such mutant, DsRed-Monomer, with a total of 45 amino acid 
substitutions in native DsRed, has shown improved fluorescence characteristics without 
the toxic oligomerization seen for the native protein.  In our laboratory, we have 
demonstrated that DsRed proteins have a unique and selective copper-binding affinity, 
which results in fluorescence quenching.  This copper-binding property was utilized in 
the purification of DsRed proteins using copper-bound affinity columns.  
The work presented here has explored the mechanism of copper-binding by 
DsRed-Monomer using binding studies, molecular biology, and other biochemical 
techniques.  Another focus of this thesis work was to demonstrate the applications of 
DsRed-Monomer in biochemical studies based on the copper-binding affinity and 
  xi 
fluorescence properties of the protein.  To achieve this, we have focused on genetic 
fusions of DsRed-Monomer with peptides and proteins.  The work with these fusions 
have demonstrated the feasibility of using DsRed-Monomer as a dual functional tag, as 
both an affinity tag and as a label in the development of a fluorescence assay to detect a 
ligand of interest.  Further, a complex between DsRed-Monomer-bait peptide/protein 
fusion and an interacting protein has been isolated taking advantage of the copper-
binding affinity of DsRed-Monomer.  We have also demonstrated the use of non-natural 
amino acid analogues, incorporated into the fluorophore of DsRed-Monomer, as a tool 
for varying the spectral properties of the protein.  These mutations demonstrated not only 
shifted fluorescence emission compared to the native protein, but also improved 
extinction coefficients and quantum yields.  
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CHAPTER 1.  FLUORESCENT PROTEINS 
 
 
1.1 Fluorescent Proteins 
 
In recent years a number of optically active proteins have been isolated and 
examined.  These proteins have revolutionized the field of biotechnology and 
biochemical research.  Such proteins emit fluorescence and bioluminescence in a number 
of ways including autocatalytic chromophore formation, and addition of an interacting 
substrate.  One such family of proteins forms a fluorescently active chromophore from a 
tri-peptide sequence surrounded by a beta-barrel.  These chromoproteins include a green 
fluorescent protein, GFP, and a red fluorescent protein, DsRed, and their mutants.  While 
fluorescent proteins have offered many advantages to various fields of research, a number 
of disadvantages have been identified.  Many of these proteins form oligomeric structures 
upon maturation, causing slow maturation and often, cellular toxicity.  Additionally many 
of these naturally occurring proteins show poor extinction coefficients and quantum 
yields.   Various mutagenesis studies have been done on fluorescent proteins, including 
directed evolution and point mutations, to address these issues, often resulting in 
improved biological and spectral properties.  Fluorescent proteins have been utilized for a 
number of biochemical and detection studies including cell tracking studies, to explore 
folding pathways, as qualitative reporters, and labels for analytical applications.  
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1.2 DsRed 
 
1.2.1 Discovery and Spectral Properties of DsRed 
 
 DsRed is a naturally occurring red fluorescent protein, initially isolated in 1999, 
by Lukyanov and colleagues [1].  The gene for this protein was isolated from the Indo-
Pacific sea anemone Discosoma striata.  It was speculated that such corals contain 
fluorescent pigments to protect them from harmful UV radiation.  This fluorescence also 
permits conversion of blue light to a longer wavelength suitable for photosynthesis by 
algal endosymbionts.  Organisms living in deeper ocean environments, where ambient 
light is depleted of low-energy components, need this conversion mechanism from short 
to longer wavelength light.  Therefore the presence of fluorescence activity in coral is 
crucial to the survival of sea organisms.  While corals utilize the red pigments as 
sunscreen against damaging radiation, we can use these pigments for a number of 
biochemical studies, based on their red emission spectra. 
Lukyanov and coworkers successfully isolated six brightly fluorescent proteins 
[2], from a number of body parts of the coral.  This work resulted in the isolation of genes 
for six proteins with 26-30 % amino acid sequence identity to GFP.  Of the six proteins 
isolated five of them were green emitting and one red emitting, DsRed.  DsRed is 
composed of 225 amino acid residues with a molecular mass of 25.4 kDa, with an 
excitation and emission wavelength maximum of 558 and 583 nm, respectively.  DsRed 
shares 26 % amino acid sequence identity with GFP, while the excitation and emission 
maximum are far red-shifted, indicating distinct differences in the chromophore 
structures of the two proteins (Table 1).    
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Table 1:  Spectroscopic properties of green fluorescent protein (GFP), tetrameric DsRed-
Express, and DsRed-Monomer 
  Size (kDa)  λexcitation (nm)  λemission (nm)  ε (M‐1cm‐1)  Quantum Yield (%) 
GFP  26.9  488  509  55,000  0.60 DsRed‐Express  89.0  557  579  38,000  0.40 
DsRed‐Monomer  26.8  556  586  35,000  0.04 – 0.25 
 
While DsRed demonstrates a number of desirable properties: resistance to 
photobleaching, pH insensitivity over a wide pH range, stable conformation, and red 
region emission, a number of limitations have also been identified for this protein.  For 
practical laboratory purposes the most problematic issues of these characteristics include 
the slow maturation, green emitting intermediate and oligomerization.  The chromophore 
of the tetrameric DsRed takes several days to fully mature, limiting its possible use as a 
reporter for gene expression studies [3].  DsRed also demonstrates high molecular weight 
aggregates, as seen for other Anthozoan GFP-like proteins.  It has been suggested, based 
on computational studies that these aggregates form as a result of electrostatic 
interactions between the negatively charged protein surface and the positively charged, 
basic, residues at the N-terminus.  These limitations described for DsRed have been 
addressed through a number of mutation studies, utilizing both random and site-directed 
mutagenesis techniques. 
 
1.2.2 Maturation and Oligomerization of DsRed 
 
The DsRed chromophore is extremely slow to mature, taking several days at room 
temperature to reach full red expression.  This red chromophore forms through a green 
intermediate, which is seen at about 7 hours post induction.  After 48 hours this green 
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emission completely disappears and red fluorescence reaches > 90 % maximal intensity 
[3].  
Crystallographic studies of DsRed reveal that it exists as a tetramer even at 
nanomolar concentration.  This oligomerization has been the speculated cause of the slow 
maturation seen for DsRed; since it requires more time for all four chromophores within 
the tetramer structure to fully mature.  It has also been suggested that this tetrameric form 
may be responsible for DsRed’s resistance to photobleaching, which is four to fivefold 
greater than that of GFP [4, 5].  
The DsRed tetramer, based on X-ray crystallography studies, forms from four 
individual units, each made up of an 11-stranded β barrel with a central helix (Figure 1).  
This central helix consists of the chromophore and α helical caps on each of the ends of 
the barrel [6].  Although, as previously stated, DsRed shares only 26 % amino acid 
sequence identity with GFP, their three dimensional structures are nearly identical.  The 
superimposed structures reveals that the loops in DsRed are shorter than those in GFP, 
due to a reduced number of amino acids in the comparable loop regions and higher 
hydrophobicity of the residues present.  Further, a pronounced bulge is seen centered 
around Ser146 in DsRed, a similar bulge is not seen for GFP in this region.  Finally 
residues 97-100 and 140-145 are significantly closer to the chromophore in DsRed, 
compared to GFP, which probably impacts chromophore formation. 
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Figure 1:  X-ray crystal structure of DsRed [7]  
 
1.3 DsRed-Monomer 
 
1.3.1 Construction of DsRed-Monomer 
 
Since the discovery of DsRed, work has been done to address the limitations seen 
for the native tetrameric protein; much of this work has focused on the need to create a 
monomeric mutant.  Yanushevich et al. [8] developed the first commercially available 
non-aggregating mutant of DsRed, in 2002.  This group focused on mutations at the 
charged N-terminus of a number of previously described mutants, E57 (V105A, I161T, 
S197A) [9], E5 (V105A, S197T) [10], and ds/drFP616 [11].  From the results of these 
initial N-terminally focused studies, further substitutions; R2A, K5E, and K9T, in 
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different combinations were examined.  The R2A showed the greatest effect on the 
aggregation of the E57 mutant.  However, mutant E57-NA with all three of these 
mutations showed the best results with regard to aggregation and spectroscopic 
properties, which are comparable to E57.  This E57-NA mutant became the first 
commercially available non-aggregating DsRed, DsRed2. 
    While Yanushevich’s DsRed2 was the first commercially available non-
aggregating mutant of DsRed, Campbell et al. [4] produced a further monomeric DsRed 
shortly after.  Campbell initially reduced the tetrameric DsRed to a dimer via a single 
point mutation, I125R.  This mutation however led to a decrease in the red fluorescence 
of the protein with an increase in the green intermediate component, and increased 
maturation time.  Utilizing directed evolution Campbell et al. identified mutants of this 
dimer, which showed the desired optical and physical properties.  From this pool of 
mutants Dimer2 was isolated with 16 additional mutations.  These 17 mutations are 
located at a number of sites within the final protein structure, specifically eight internal to 
the β-barrel, two at the AB interface, four surface mutations and three that are known to 
reduce aggregation.  From this Dimer2 a tandem dimer, tdimer2, was produced, via a 
polypeptide linker of 12 amino acids, which demonstrated excitation and emission 
identical to Dimer2 with an improved extinction coefficient.  This increased extinction 
coefficient was attributed to the presence of the two absorbing chromophores. Through a 
series of point mutations in this tdimer2, a first generation monomer, mRFP.1, was 
identified.  Further use of directed evolution yielded mRFP1, the first true monomer of 
DsRed with 33 amino acid substitutions in native DsRed.  
This mRFP1 mutant was further improved by Shaner et al. [12] through a series 
of mutation studies and screened both manually and by fluorescence-activated cell 
sorting (FACS)-based screening.  From these mutation studies a number of mutants were 
isolated which showed differing emission maxima, increased tolerance to N- and C-
terminal fusions, improved extinction coefficients, quantum yields and high 
photostability.  While individual improvements were seen for all of the mutants no one 
mutant showed improvement in all of these areas.  This was addressed by a further series 
of amino acid substitutions, focusing on the residues around the chromophore, leading to 
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mutant mRFP1.1.  The sensitivity of this mutant to N-terminal fusion was addressed by 
replacing the first seven amino acids with MVSKGEE followed by a four amino acid 
linker, NNMA (6a-6d).  The C-terminal of the protein was also replaced with the last 
seven residues of GFP (mRFP1.3).  Two additional point mutations in this mutant created 
mRFP1.4, which showed improved chromophore folding.   
The work of Yanushevich, Shaner, Campbell and others, described above, lead to 
the optimized monomeric DsRed, DsRed.M1 described by Strongin et al. [13].  This 
protein DsRed.M1, or DsRed-Monomer, is now commercially available through 
Clontech.  DsRed-Monomer contains 45 amino acid substitutions in native DsRed; it 
overcomes the oligomerization seen for the native protein.  This non-aggregating species 
was verified via a number of methods, which led to an obtained molecular weight of 
~28kDa, consistent with a single DsRed unit.  The DsRed monomers generated by both 
directed evolution and site-specific mutagenesis of amino acid residues have an almost 
ideal set of properties for biological sensing and analytical applications.  A more detailed 
discussion of the work, which led to the creation of this monomeric DsRed variant, is 
presented in Appendix A. 
 
1.3.2 Spectral Properties of DsRed-Monomer 
 
While the spectral properties of DsRed-Monomer are less ideal than those seen 
for the tetrameric DsRed, DsRed-Express (Clontech, Palo Alto, CA), the maturation is 
much faster.  The chromophore of this protein fully matures within hours of induction 
and shows none of the parasitic green florescence reported for the native DsRed.  DsRed-
Monomer displays a fluorescence excitation maximum at 556 nm and emission at 586 
nm, however the range of quantum yields reported, by a number of groups, for this 
protein is much lower (Table 1) [4, 13].    
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1.3.3 X-ray Crystal Structure of DsRed-Monomer 
 
The chromophore of DsRed-Monomer is formed internally from a tripeptide 
sequence composed of Gln66-Tyr67-Gly68.  This chromophore is autocatalytically 
formed via cyclization and dehydrogenation of the tripeptide (Figure 2).  The 
environment around this chromophore is more polar than that of GFP, consisting of 
charged residues such as lysine (residues 70, 83, and 163) and glutamine (residue 148) 
which closely interact with the chromophore [6].  The phenolate oxygen of the 
chromophore interacts with Ser146 and Lys63, while Gln223 and Asn42 form hydrogen 
bonds with Gln66.  These interactions help position the Gln66, necessary for red 
fluorescence.  
The crystal structure of DsRed-Monomer was generated by Strongin et al. [13], 
the results of these studies are presented in Table 2 and displayed in Figure 3.  The 
crystallized DsRed-Monomer displays spacegroup P212121 with one molecule in the 
asymmetric unit.  Since native DsRed is a naturally occurring tetramer, as previously 
discussed, the intermolecular contacts in the DsRed-Monomer crystal lattice differ 
significantly from those of DsRed, specifically the intermolecular interactions that define 
the 222 symmetry of the tetramer are completely disrupted.  Additionally, the 
intersubunit distances and orientations are different from those in the tetramer.  
Regardless of the numerous amino acid substitutions in this monomer, a total of 45, the 
structure reveals no gross distortion of the GFP-like fold, seen in the units of the tetramer.  
The largest conformational distortions appear in the loop regions.  There are several 
surface mutations that disrupt intramolecular interactions in the tetramer and that actually 
form interactions in the monomer.  These include Arg153 and Lys158, which mediate 
interactions in the polar and hydrophobic interfaces.  In the monomer this 153 residue is 
replaced with a Gln disrupting the salt bridge with Glu100 and forming a new 
intramolecular hydrogen bond between Gln153 and Lys158.  In DsRed-Monomer the 
Tyr26 fills a void by packing against the service and forming hydrogen bonds with 
Glu28. 
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Figure 2:  The chromophore of DsRed, generated autocatalytically in the presence of 
molecular oxygen from the Gln66-Tyr67-Gly68 tripeptide [6]  
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Figure 3:  X-ray crystal structure of DsRed-Monomer [13] 
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Table 2:  X-ray crystal structure data for DsRed (wild type) and DsRed-Monomer [7, 13] 
  DsRed (wild type)  DsRed‐Monomer 
Space group  P21  P212121 
Unit cell dimensions (Å)  a=55.7, b=127.2, c=57.1 β=100.4°  a=38.9, b=62.2, c=81.9 α=β=γ=90° Molecules per asymmetric unit  4  1 X‐ray source  ALS beamline 5.0.1  APS 14BM‐C 
Wavelength (Å)  1.000  0.900 
Resolution range (Å)  40‐1.4 (1.45‐1.40)  50‐1.59 (1.65‐1.59) 
Total/unique observations  363894/148353  181 013/27 397 Completeness (%)  96.8 (93.2)  99.7 (99.6)  
<I/sigI>  18 (1.9)  43.7 (6.7) 
Rsym (%)  5.1 (35.7)  5.5 (39.7)  
Further deviations in structure from the tetramer were seen in and around the 
chromophore of the DsRed-Monomer.  Specifically a +10 degrees and -11 degrees 
deviation from coplanarity from the phenolate plane is seen for the chromophore of the 
monomer.  Additionally the Lys70 no longer interacts with Glu215 or Ser197; instead 
this residue forms a salt bridge with Glu148.  Replacing this Lys70 side chains, a water 
molecule mediates a network of hydrogen bonds between Glu215, Ser197 and the 
repositioned Lys70.  This Lys residue may also adopt multiple conformations and sweep 
out in an arc above the chromophore.  This Lys70 may also be further modulated by the 
V71A and S179T.  
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1.3.4 Advantages of DsRed-Monomer 
 
 Through the use of point mutations and directed evolution a true monomer of 
DsRed, DsRed-Monomer, is now commercially available.  This protein offers a variety of 
spectral characteristics with advantages and disadvantages compared to the commercially 
available tetramer of DsRed.  This protein offers strong emission in the red region of the 
spectrum, ideal for use as markers for gene expression and protein localization in 
biological systems, due to decreased background signal in the red region of the spectrum, 
as compared to the green, for most organisms.  Additionally this monomer demonstrates 
no aggregation or oligomerization and allows for full maturation of the chromophore 
within hours.        
 
 
1.4 Copper-Binding Characteristics of DsRed and its Variants 
 
 DsRed and its mutants have demonstrated the ability to bind copper ions, 
resulting in a quenching of their fluorescence [14, 15].  Kopelman and colleagues [15] 
developed a sensitive fluorescent probe for the detection of mono- and divalent copper 
ions, utilizing wild type DsRed.  Copper ions are important for numerous biological and 
biosynthesis pathways, copper-containing proteins are key players in the human nervous 
system and many neurological conditions are linked to defects in copper homoeostasis.  
For example Menkes’ and Wilson’s disease, both neurological disorders, are caused by 
an inability to metabolize copper.   Additionally copper has been widely used in 
industrial processes and is a source of pollution in the environment, micromolar amounts 
of copper are toxic within a biological environment.  The availability of copper detection 
methods for biological and environmental samples is of great significance. 
 The work of Kopelman and colleagues yielded a nanomolar detection limit, with 
90 % fluorescence quenching at 2.5 µM Cu2+ and 75 % at 2.5 µM Cu+.  Kd values for this 
tetrameric DsRed from this work were found to be 540 ± 90 nM and 450 ± 60 nM for 
Cu2+ and Cu+ respectively.  The binding, and subsequent fluorescence quenching, was 
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also found to be very selective to copper ions, compared to Mn2+, Fe2+/3+, Co2+, Ni2+, 
Cd2+, Ag2+, Hg2+, Pb2+, Mg2+, and Ca2+.  Finally, studies indicated that this quenching 
was reversible, with up to 90 % of fluorescence retrieved, within two minutes, upon the 
addition of a metal chelator such as ethylenediaminetetraacetic acid (EDTA). Such 
studies indicate that the tetrameric DsRed contains a copper-binding site, which is not 
present in other fluorescent proteins, for example GFP.   
Further studies by Eli and Chakrabartty [14] explored the metal binding affinity of 
red shifted DsRed mutants.  One mutant, tetrameric Rmu13 (F91L, V105A) demonstrated 
copper sensitivity with a binding constant of ~11 µM for this mutant and ~15 µM for 
DsRed.  Eli et al. demonstrated that their copper sensor, utilizing the Rmu13 mutant, 
could reliably detect Cu2+ at concentrations between 0.1 and 100 µM, in vitro or in vivo.  
Initial work in our laboratory has demonstrated the selective copper-binding affinity and 
fluorescence quenching of DsRed-Monomer.  Rahimi et al. reported that the fluorescence 
of DsRed-Monomer was quenched by greater than 90 % in the presence of 500 µM of 
copper ions (Figure 4).  This work lead to a detection limit for Cu2+ of 0.8 µM [16], 
indicating that DsRed-Monomer can be used in the development of a copper sensor.  This 
study also demonstrated that the metal affinity seen for DsRed-Monomer was selective 
for copper, compared to a number of other mono- and divalent metals, namely calcium, 
magnesium, iron, cobalt, nickel, zinc, and barium [17].  
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Figure 4:  Fluorescence quenching of DsRed-Monomer in the presence of increasing 
concentrations of Cu2+ [17] 
 
Further, this copper-binding affinity has also been utilized by Rahimi et al. [16] as 
an efficient purification strategy for DsRed-Monomer.  The crude DsRed-Monomer was 
bound to an immobilized copper charged column and eluted with an imidazole-
containing buffer (Figure 5).  Purification of DsRed-Monomer, using this strategy, 
demonstrated greater than 95 % purity of recovered protein, and 95 % recovery of total 
protein [16].  Subsequent work, presented in this thesis, has been done to determine the 
mechanism of this quenching and to utilize this, and other properties of DsRed-Monomer, 
for sensing and detection applications. 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Figure 5:  SDS-PAGE gel of copper-affinity purified DsRed-Monomer, crude DsRed-
Monomer (lane 1), pure DsRed-Monomer (lane 2), molecular weight protein marker 
(lane 3) [16] 
 
 
1.5 Copper-Binding Proteins 
 
 Copper is an essential trace element in living organisms.  It plays a critical role in 
the activation of a variety of proteins with functions including electron transfer, oxygen 
transport in the body and oxygen insertion into a substrate [18].  However, in addition to 
these necessary functions, free copper ions within the cellular environment can be toxic, 
even at µM concentrations.  As reported by us and other groups DsRed proteins show a 
unique and selective copper-binding affinity, however in addition to this fluorescent 
protein a number of naturally occurring copper-binding proteins have also been identified 
which control these levels of free copper within the cell, restricting their movement.  
Such proteins are frequently employed within the cellular environment to bind free 
copper ions, guiding them to their appropriate locations in the cell.  Copper-binding 
proteins can be classified by a number of characteristics, including spectral properties, 
function, binding site, and binding affinity [19, 20].  These proteins demonstrate a wide 
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range of copper dissociation constants from 10-6 – 10-17 M.  One such group of copper-
binding proteins, the copper chaperones, is divided into three types. 
 Type 1 “blue” copper proteins have a visible absorption band near 600 nm.  These 
copper enzymes generally contain a four-coordinated, distorted tetrahedral, copper ion.  
However a five-coordinated copper ion has also been seen for a limited group of these 
proteins.  The structural motif at the active site consists of a (His)2CysX sequence, where 
X is normally a Met residue (Figure 6).  Type 2 “non-blue” copper proteins, have a 
visible absorption band between 350 and 420 nm.  The copper in this type of proteins is 
usually found in a square planar or tetragonal coordination.  These proteins form their 
copper-binding site through a number of motifs including (Cys)4, (His)4H2O, 
(His)2(Tyr)2(H2O), or (His)2(Tyr)2 with the copper coordinated to N, O, or S of these 
residues (Figure 7).  Type 3 “binuclear” copper proteins have a strong absorption band 
near 330 nm.  These are characterized by an antiferromagnetically-coupled pair of copper 
ions (Figure 8), each coordinated by three His residues.  
  
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 6:  Copper-binding site of azurin, a type 1 copper chaperone [21] 
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Figure 7:  Copper-binding site of HAH1 (Atx1), a type 2 copper chaperone [19] 
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Figure 8:  Copper-binding site of hemocyanin, a type 3 copper chaperone, demonstrating 
the binuclear copper complex [19] 
 
 In addition to the binding motifs described above, more complex cooper-binding 
sites have also been identified for copper chaperones.  These copper-binding sites, with di 
and trinuclear copper centers, display properties indicative of both type 2 and 3 copper 
chaperones.  For example trinuclear copper centers, such as those seen for blue oxidases, 
which demonstrate type 2 and type 3 properties as well as dinuclear copper centers seen 
for cytomchrome c oxidase have been described.  Copper-binding proteins have been 
shown to utilize both single and combinations of multiple copper-binding motifs within a 
single protein.  The proteins and binding motifs described above belong to the group 
commonly referred to as copper chaperones, a second group of copper-binding proteins, 
so called prion proteins, also demonstrate copper-binding affinity within the cellular 
environment. These prion proteins form complexes with the copper ions in a 4 
coordinated structure, similar to that seen for the type 1 blue copper proteins, from a 
HGGGQ peptide sequence.  A variety of dissociation constants have been reported for 
prion proteins from 0.03 nM – 100 nM [22-24].  A further copper-binding site, frequently 
referred to as the copper-binding peptide, demonstrates one of the lowest dissociation 
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constant of these copper-binding proteins, 1 x 10-17 M.  This simple tripeptide acts as a 
quadridentate ligand to create complexes with copper through an amino group, two 
deprotonated amide groups and an imidazole pyridine nitrogen (Figure 9) [25].  The 
initial work in this thesis has focused on defining the mechanism of the unique 
fluorescence quenching seen for DsRed-Monomer in the presence of copper ions.  In 
addition to defining this mechanism, further work aimed at identifying the binding site of 
this protein has also been explored. 
 
 
 
  
 
 
     
Figure 9:  Copper-binding site of the copper-binding peptide, GlyGlyHis    
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CHAPTER 2.  MECHANISM OF COPPER INDUCED FLUORESCENCE 
QUENCHING OF RED FLUORESCENCE PROTEIN, DSRED-MONOMER 
 
 
2.1 Introduction 
 
As discussed in the previous chapter, a number of fluorescent proteins have 
recently been isolated and explored.  Isolation and characterization of these proteins has 
expanded the possible applications of fluorescent proteins into multi-color labeling, 
resonance energy transfer, and intracellular tracking studies [26-29].  To date, red 
fluorescent proteins have been mainly employed as genetically encoded fluorescent 
probes for cellular applications.  However, other fluorescent proteins have also been 
employed in novel applications, for example GFP was employed as an intracellular 
calcium detector, as a chloride indicator, as a pH indicator and in ligand monitoring using 
receptor inserted GFPs [30-35].  Only recently we, and others, have found that red 
fluorescent proteins, namely DsRed and its variants, bind copper ions selectively in the 
presence of other divalent cations resulting in a quenching of their native fluorescence 
[14-17].  By relating fluorescence quenching of DsRed with copper concentration, in 
vitro biosensing systems for copper determination have been developed [15, 17].  
Moreover, this ability to bind copper ions can now be utilized in the intracellular 
detection of copper, at µM levels based on the fluorescence of DsRed.   
Copper is an important cofactor of several enzymes and plays a significant role in 
several cellular pathways and disease pathogenesis [36-38].  Therefore, the availability of 
genetically encodable probes such as DsRed, which can be targeted to specific organelles 
for detection of copper, would prove highly beneficial.  Furthermore, this copper-binding 
can serve as a unique tool for affinity purification, as well as for cooper sensing.  In that
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regard, it is essential to understand the binding of copper to DsRed, its mechanism of 
quenching, and the spectral changes in DsRed proteins in the presence of copper.   
In the work presented in this chapter, we have characterized the mechanism of 
fluorescence quenching of DsRed-Monomer in the presence of copper, using 
spectroscopic tools.  We have also performed studies to identify possible amino acid 
residues involved in this binding.  Sequence comparison with known copper-binding 
proteins and computational studies have been used to explore possible copper-binding 
motifs within the protein.  DsRed-Monomer was selected for this study because our 
laboratory has, previously, developed biosensors for copper detection utilizing this 
DsRed variant [39].  In addition, other copper-binding DsRed proteins, specifically, 
DsRed2, native DsRed, and Rmu13 share > 80 % identity with DsRed-Monomer, 
suggesting that DsRed-Monomer may serve as a representative member of the copper-
binding family of DsRed proteins.  
 
 
2.2 Materials and Methods 
 
2.2.1 Protein Expression and Purification 
 
 Expression and purification of DsRed-Monomer was performed using previously 
established protocols.  Briefly, the plasmid DsRed-Monomer was obtained from 
Clontech.  This plasmid was transformed into E. coli, JM107 and expressed in LB broth.  
LB media containing 100 µg mL-1 ampicillin was prepared.  A 5 mL sample of LB was 
inoculated with the E. coli containing the plasmid pSKD1 and incubated overnight in a 
shaker at 37 °C.  The culture was transferred to a 200 mL sample of LB and grown to an 
OD420 of 0.5 and induced with isopropyl-β-D-thiogalactoside (IPTG, 0.5 mM final 
concentration), and grown for a further 5 h, with shaking, 250 r.p.m., at 37 °C and 
collected by centrifugation, 4000 r.p.m., for 30 min at 4 °C.  The pellet was dissolved in 
the PBS-binding buffer (100 mM Na2PO3, 50 mM NaCl, pH 7.0) and sonicated for 5 min 
to lyse the cells.   
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The protein was purified using a Ni Sepharose high-performance affinity column, 
charged with copper [16].  A volume of 1.5 mL of the Ni Sepharose high-performance 
beads was centrifuged and the storage ethanol poured off.  The beads were resuspended 
in sterile water and applied to the column.  A volume of 2 mL of the stripping buffer 
(0.02 M sodium phosphate, 0.5 M NaCl, 0.05 M EDTA, pH 7.4) was applied to the 
column.  The column was rotated overnight to fully remove the Ni from the beads.  The 
column was washed with multiple column volumes of sterile water, and 1.5 mL copper 
sulfate (0.1 M) was applied.  The column was again rotated, for at least 2 h to assure full 
binding of the Cu2+ ions to the beads.  The column was washed with up to 10 column 
volumes of PBS-binding buffer to remove all unbound copper.  A volume of 1.5 mL 
aliquots of the crude protein was applied to the column, with the column being rotated for 
2 h between additions.  The column was again washed with up to 10 column volumes of 
PBS-binding buffer to remove anything not bound to the copper immobilized column.  
Wash buffers (0.05 M sodium phosphate, 0.3 M NaCl, ph 8.0, containing 0.001 to 0.01 M 
imidazole) were used to wash the column.  The protein was eluted by the final wash step, 
with the buffer containing 0.01 M imidazole (0.05 sodium phosphate, 0.3 M NaCl, pH 
8.0).  The purified protein was collected and dialyzed to remove the imidazole, using 
PBS buffer (0.05 M sodium phosphate, 0.05 M NaCl, pH 8.0).   Protein purity was 
determined via SDS-PAGE gel electrophoresis and concentration by BioRad assay. 
 
2.2.2 Determination of Dissociation Constant for Cu2+ 
 
 The purified protein was dialyzed against 20 mM MOPS buffer, pH 7.4, to 
remove the imidazole.  The imidazole-free protein solution was passed through a Chelex-
100 column to remove any trace levels of Cu2+.   For the binding study 100 µL of 
different concentrations of a copper solution were added to 100 µL of 1 µM of DsRed-
Monomer.  The fluorescence readings were obtained and buffer corrected.  The 
fluorescence intensity ratio, [F/F0], was plotted against the copper concentration to obtain 
the copper dissociation constant for DsRed-Monomer.  This fluorescence was measured 
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(Varian Cary Eclipse Fluorescence Reader, Palo Alto, CA) by exciting the sample at 556 
nm and reading the emission at 597 nm. 
 
2.2.3 Stern-Volmer Plots 
 
 A volume of 100 µL of different concentrations of Cu2+ solution was added to 
100 µL of 1 µM protein in 20 mM MOPS, pH 7.4, in an individual microtiter well.  After 
the addition of the copper, the sample was incubated at a number of different 
temperatures (16, 25 and 30 °C).  Fluorescence readings were recorded for each 
temperature at each concentration, as described above.  Again the results were buffer 
corrected and plotted. 
 
2.2.4 Spectroscopic Studies 
 
 The CD spectrum was obtained for the DsRed-Monomer.  A volume of 250 µL of 
3.3 µM protein in 20 mM MOPS, pH 7.4, was placed in a 0.2 cm cell and the CD 
absorption spectra obtained, at room temperature (Jasco J-720 Spectropolarimeter, 
Tokyo, Japan).  A volume of 10 µL of copper was added to the protein to a final 
concentration of 0.5 mM and the spectra recorded.  The collected spectra were again 
buffer corrected. 
 The UV-visible spectra were also obtained for DsRed-Monomer.  A volume of 1 
mL of 3.4 µM in 10 mM MOPS buffer, pH 7.4, was placed in a cuvette and the 
absorption spectra of the protein recorded (Perkin-Elmer UV/vis/NIR LAMBDA), at 
room temperature.  To this sample 10 µL of copper solution was added, to a final 
concentration of 0.5 mM, and the absorbance spectra recorded.  The spectra were once 
again buffer corrected. 
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2.2.5 pH Study 
 
 MOPS buffers ranging from pH 5.5 to 10.5 were prepared.  A protein solution of 
3 µM DsRed-Monomer in 10 mM MOPS buffer, pH 7.4, was mixed with the different 
pH buffers to obtain a final concentration of 1 µM at the desired pH.  Fluorescence 
intensity was recorded for each of these samples, with and without copper (300 µM). 
 
2.2.6 Metal-binding Prediction Studies  
 
 The amino acid sequence of DsRed-Monomer was examined via MetalMine [40], 
and Metsite [41].  MetalMine compares the target protein sequence with a compiled list 
of metal binding proteins and enzymes.  Metsite looks for metal binding sites within the 
sequence computationally.  MetSite uses a set of neural network classifiers trained to 
identify potential cation ion sites.  MetSite uses relative residue position, to identify 
possible metal binding sites, and therefore does not require exact side-chain atom 
placement.  This allows the results to be generated for predicted structures. 
 
 
2.3 Results and Discussion 
 
 Recent studies from a number of laboratories have found that DsRed and its 
variants bind Cu2+ selectively, resulting in quenching of the natural fluorescence emission 
at its characteristic wavelength [14, 15, 17].  Copper ion-binding of DsRed has shown 
greater than 90 % fluorescence quenching reversibility with the addition of a metal ion 
chelator, such as EDTA [15].  This selectivity and reversibility increases the usability of 
these proteins in a variety of sensing applications.  DsRed proteins can also serve as 
genetically encodable copper ion-binding fluorescent probes, which can be targeted to a 
specific subcellular compartment.  Such work would open up new avenues of research.  
This copper-binding property of DsRed-Monomer has also been utilized for affinity 
purification of the protein, using metal chelating columns [16].  The copper-binding 
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selectivity observed for DsRed is unique since GFP, and a variety of other fluorescent 
proteins, do not show any inherent metal-binding properties. 
   Fluorescence quenching seen for DsRed proteins in the presence of copper has 
been shown to have no effect on the emission wavelength maximum.  One variant of 
DsRed, DsRed2, has been examined as a highly selective and sensitive copper biosensor 
with a reported dissociation constant of 0.54 ± 0.09 µM [15].  Copper ion concentrations 
of 2.5 µM have shown greater than 90 % quenching with this protein.  Further studies 
utilizing mutants of DsRed showed moderate quenching with copper concentrations of 10 
µM [14].  Dissociation constants for these mutants, drFP583 (native DsRed) and Rmu13, 
were reported as 14.8 ± 1.7 and 10.9 ± 1.7 µM, respectively.  These constants vary 
greatly from those reported for DsRed2 by Eli et al.  Studies performed in our laboratory 
have demonstrated that DsRed-Monomer binds Cu2+ selectively.  Additionally, DsRed-
Monomer showed greater than 50 % quenching at concentrations of 3 µM copper [16].  
Using DsRed-Monomer, a detection limit for copper was found, 0.8 µM [17].  All of the 
studies reported so far have focused on the use of DsRed in the construction of copper 
biosensors. However studies were lacking, which characterize the effect of copper-
binding on DsRed-Monomer, in terms of the changes in spectral properties or the 
mechanism of this observed quenching.  To investigate these properties we have 
performed a series of spectroscopic studies using DsRed-Monomer in the presence of 
Cu2+. 
 Initially the copper dissociation constant for DsRed-Monomer was calculated, as 
a measure of the affinity for binding Cu2+.  This was calculated using the equation below 
[42]. 
 
€ 
ΔF
ΔFmax
 = 
€ 
Kd + [P]+ [Cu]± (Kd + [P]+ [Cu])2 − (4[P][Cu])
2[P]  
 
where ΔF is the change in the measured fluorescence, ΔFMAX the maximum fluorescence 
change, [P] the total protein concentration, Kd the dissociation constant of the copper-
binding site, and [Cu] the total concentration of copper.  The curve of ΔF/ΔFmax against 
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copper concentration was fitted using this equation (Figure 10).  A detailed derivation of 
this equation is presented in Appendix B.  From this data a dissociation constant of 1.7 ± 
0.3 µM was calculated for DsRed-Monomer.  This dissociation constant shows that 
DsRed-Monomer has a similar affinity for copper as that seen for DsRed2, and higher 
affinity than other DsRed variants, specifically, drFP583 and Rmu13.  Other naturally 
available copper-binding proteins and peptides have reported Kd values ranging from 10-6 
to 10-17 M [20, 23].  In comparison DsRed-Monomer, and other DsRed variants, appear to 
be relatively weak copper-binding proteins.  However, the inherent fluorescence of these 
proteins and their high selectivity for copper ions can be an advantage over other copper-
binding proteins for sensing applications.  
 
Figure 10:  Plot of ΔF/ΔFmax against copper concentration, where ΔF is the change in 
measured fluorescence and ΔF is the maximum fluorescence change      Fluorescence quenching was observed for DsRed-Monomer in the presence of 
Cu2+.  To investigate whether the mechanism of this quenching is a dynamic or static 
process we generated a Stern-Volmer plot [43] for DsRed-Monomer.  This plot was 
generated by measuring the fluorescence of the protein upon the addition of copper at a 
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variety of points of temperatures (Figure 11).  This plot showed a linear relationship, 
indicating that only one type of quenching was occurring.  From the slope of this plot the 
Stern-Volmer constant (Ksv) was calculated, as displayed in Table 3 [43].  This constant 
showed an increase, with a decrease in temperature, indicating that a static quenching 
interaction is occurring between the protein and the copper ions.  In static quenching the 
quencher forms a non-fluorescent ground-state complex with the fluorophore [43].  To 
further define the quenching seen between DsRed proteins and Cu2+, the Ksv value, 
obtained from the Stern-Volmer plot was used to calculate the quenching rate constant, 
Kq, by the following equation 
 
Kq = Ksv / τ0 
 
where τ0 represents the lifetime of the fluorophore of the protein, reported as 3.3 ns for 
DsRed [44].  The Kq value obtained for DsRed-Monomer from this study, 1012 to 1013   
M-1s-1, is 100-fold larger than the maximum scatter collision quenching constant for 
quenchers (2.0 x 1010 M-1s-1) [45].  Therefore the Kq obtained for DsRed-Monomer 
indicates that the observed quenching of this protein in the presence of copper must be 
due to the formation of a complex, as observed in static quenching. 
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Figure 11:  Stern-Volmer plots generated by adding Cu2+ to DsRed-Monomer followed 
by incubation at (square) 16 °C, (diamond) 25 °C, and (triangle) 30 °C 
 
Table 3:  Stern-Volmer constants (Ksv) determined from the slope of the Stern-Volmer 
plot and quenching rate constants determined using the equation Kq = Ksv/τ0 where Ksv is 
the Stern-Volmer constant and τ0 is the lifetime of the fluorophore  T (°C)  Ksv (M‐1)  Kq (M‐1 s‐1)  
16  48,800  1.47 x 10‐13 
25  41,200  1.24 x 10‐13 
30  30,100  9.12 x 10‐12 
   To further validate that the mechanism of this fluorescence quenching in the 
presence of copper is static, we performed UV absorption scans of DsRed-Monomer, in 
the presence and absence of Cu2+.  Dynamic quenching affects only the excited states of 
the fluorophore whereas a static quenching process affects its’ ground state [43].  
Therefore the static quenching process leads to a change in the absorption spectra.  The 
absorption spectra obtained for DsRed-Monomer in the presence of copper, showed that 
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the absorbance intensity was affected by the addition of copper, compared to the same 
protein concentration in the absence of copper (Figure 12).  With a single equivalence of 
bound copper, the absorbance and the extinction coefficient of the protein decreased at its 
characteristic wavelength of 556 nm (Figure 12, Table 4).  The overall shape and pattern 
of peaks was retained for the protein in the presence of copper compared to the peaks 
obtained for the protein alone.  A static quenching process typically yields changes in the 
absorption profile [43, 45], however, this was not seen for DsRed-Monomer.  The 
observed anomalous behavior seen for DsRed-Monomer can be explained as following.  
It is known, that in the case of proteins, only fluorophores located at the surface can be 
dynamically quenched whereas a static process quenches internal fluorophores.  This 
dynamic process is excluded for internal fluorophores due to the higher hydrophobicity in 
the protein’s interior.  In the case of DsRed, the chromophore is well shielded inside a β-
barrel and hence is not accessible for dynamic or collisional quenching.  Taking this 
factor into consideration and the Stern-Volmer constants obtained in our study, we 
hypothesize that the fluorescence quenching of DsRed-Monomer in the presence of 
copper follows a sphere of action static quenching model.  This indicates that the 
quencher forms a contact at a defined site on the protein, adjacent to the fluorophore, 
leading to the formation of a non-fluorescent species.  This is further supported by the 
observation that the absorption spectral profile of this protein does not change in the 
presence of copper, only the intensities of the peaks were seen to change, as expected for 
a sphere of action static mechanism [43, 45]. In a static quenching model the quencher 
forms a non-fluorescent ground-state complex with the fluorophore.  However, in a 
sphere of action static quenching model, the quencher forms a complex on a specific site 
on the surface of the protein, adjacent to the fluorophore.  This close proximity, of the 
quencher to the fluorophore, at the moment of excitation leads to the formation of the 
non-fluorescent species.  The radii of the solvent shells of both the fluorophore and the 
quencher define the maximum distance between the fluorophore and the quencher for this 
type of fluorescence quenching to occur.  Based upon the interactions seen for the four 
chromophores within the tetrameric DsRed structure [6], we believe that this maximum 
distance would be within ~30 angstroms of the chromophore for such a quenching effect 
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to be seen.  Since we hypothesize that in the case of DsRed proteins, copper ions form a 
complex with specific amino acid residues on the protein, further work was done to 
identify this binding site.  This complex formation can lead to the formation of a non-
fluorescent species in three ways, (i) by affecting the hydrogen-bonding network of the 
chromophore, (ii) by bringing copper close to the chromophore such that it contacts the 
excited-state of the chromophore, (iii) by causing conformational/structural changes in 
the protein.   
 
Figure 12:  UV-Visible absorption spectra of DsRed-Monomer in the presence () and 
absence (---) of Cu2+ 
 
Table 4:  UV-Visible and CD spectral characteristics of DsRed-Monomer in the presence 
and absence of Cu2+ DsRed‐Monomer  ε  (M‐1cm‐1)  α‐helix (%)   β‐sheet (%)  Random coil (%) With Copper  62,700  5  47  48 
Without Copper  57,600  5   47  48 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We investigated whether the binding of copper to DsRed-Monomer caused any 
structural or conformational changes within the protein, leading to quenching of the 
fluorescence.  To achieve this we monitored the far-UV CD spectra of the protein with 
and without copper.  The spectra and the percentages of the secondary structure (Table 4) 
were found to be identical both in the presence and absence of copper.  This result 
suggests that the observed quenching in DsRed-Monomer is not due to any structural or 
conformational changes in the protein upon copper-binding. 
 From the Stern-Volmer study and the CD spectroscopy results we can deduce that 
copper forms a complex with specific amino acid residues of DsRed-Monomer, while the 
structural and conformational integrity is maintained.  To identify possible amino acid 
residues involved in this copper-binding we studied the effect of pH on this copper-
binding, by monitoring any change in the fluorescence intensity of DsRed-Monomer with 
a change in pH, both in the presence and absence of copper.  In the absence of copper the 
protein showed no pH dependence across a range of pH from 5 to 12, showing no change 
in fluorescence intensity.  However in the presence of copper this plot showed a dramatic 
shift in fluorescence intensity from pH 6 to 8.5.  The pKa value of 7.3 calculated for 
DsRed-Monomer was obtained from this plot (Figure 13).  This pKa value suggests that 
either Cys or His residues may be involved in the copper-binding of DsRed-Monomer. 
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Figure 13:  The plot represents the effect of pH change on the fluorescence intensity of 
DsRed-Monomer in the presence (squares) and absence (triangles) of Cu2+     To further evaluate the identity and position of possible metal binding motifs 
within the structure and sequence of DsRed-Monomer, two computational programs were 
utilized.  MetalMine and Metsite were used to help locate metal-binding sites within the 
DsRed-Monomer.  Sequence identity comparison with known metal-binding proteins is a 
common method of locating metal-binding sites within a protein or enzyme.  MetalMine 
evaluated the sequence of DsRed-Monomer compared to known copper-binding motifs, 
in an attempt to identify sequence homology.  Furthermore, the x-ray crystal structure of 
a protein can be evaluated computationally to determine the possibility of metal-biding 
sites within a sequence.  For DsRed-Monomer we utilized the Metsite website for such a 
computational study.  The MetalMine sequence comparison did not indicate the presence 
of any known copper-binding motifs, within the sequence of DsRed-Monomer, 
comparable to known copper-binding proteins and enzymes.  This suggests that the 
copper-binding site present in DsRed-Monomer is not one of the traditionally accepted 
binding motifs discussed in Chapter 1.  This result is not surprising since the dissociation 
constant for DsRed-Monomer, 1.7 µM, is relatively low compared to those reported for 
traditional copper-binding proteins, 10-6 – 10-17 M.  The Metsite predictive program, 
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however, did identify a number of possible metal binding sites with varying degrees of 
metal affinity.  By comparing the results of the Metsite predictions with the X-ray crystal 
structure of DsRed-Monomer, two possible binding sites were identified that include two 
His residues, His25 and His216 (Figure 14).  Both of these His residues are external to 
the beta barrel of DsRed-Monomer and have neighboring Gly residues, which could also 
assist in copper-binding.  His25 has one set of neighboring Gly residues (Gly126-Gly20) 
which could assist in copper-binding.  The His216 residues, on the opposite side of the 
beta barrel of DsRed-Monomer, has another set of Gly residues (Gly40-Gly35) in 
neighboring positions.  Either of these sites may yield a GlyGlyHis copper-binding 
peptide, which, as described in the previous chapter, demonstrates one of the strongest 
copper-binding affinities, 10-17 M.  However, the X-ray crystal structure suggests that 
these Gly residues will be internal to the beta barrel and not available for binding.  These 
internally arranged Gly residues might still help the bound copper ions to come into 
contact with the chromophore as described in our quenching model, while their less than 
ideal positioning may explain the low dissociation constant seen for DsRed-Monomer.  
Alternatively, the low binding constant observed for DsRed-Monomer, compared to other 
known copper-binding proteins, may suggest that the His residues bind these copper ions 
alone or with only minor assistance from the neighboring residues.  
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Figure 14:  The possible copper-binding sites of DsRed-Monomer using the reported x-
ray crystal structure [13] (A) His216 (green), Gly35 (red), Gly40 (peach), (B) His25 
(green), Gly20 (peach), Gly126 (plum)  
 
2.4 Conclusion 
 
 In summary, DsRed-Monomer has previously shown a unique selectivity for 
copper-binding.  This copper-binding has been used in the development of affinity-based 
purification of DsRed and copper sensing applications [15, 16].  The work presented here 
has focused on biochemical; spectroscopic and computational studies to determine the 
mechanism of this observed fluorescence quenching in the presence of copper.  The 
binding of copper to DsRed-Monomer appears to have no effect on the overall structure 
of this protein, as seen by far-UV CD spectral analysis.  Deviations in the UV-visible 
absorbance values were seen in the presence of copper, however no shift in the 
absorbance peaks was observed in the presence of copper.  Both the UV-visible and the 
Stern-Volmer constants suggest that the fluorescence quenching seen for DsRed-
Monomer follows a sphere of action static quenching model, indicating the formation of a 
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complex between specific residues of the protein and copper ions.  This binding brings 
the copper ion into close proximity to the excited state of the chromophore, creating a 
non-fluorescent species.  Based on the pH study, either cysteine or histidine residues 
were identified to be involved in binding copper ions in DsRed-Monomer.  Furthermore 
the Metsite results, when compared to the X-ray crystal structure of DsRed-Monomer, 
indicated the possible involvement of His25 or His216 in the copper-binding, possibly 
creating a GlyGlyHis binding site with neighboring Gly residues.  The results presented 
here provide the groundwork for future investigations in identifying the copper-binding 
site in DsRed-Monomer.  In that regard, site-directed mutagenesis, of His25 and His216, 
is envisioned to further evaluate their role in copper-binding.    
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CHAPTER 3.  DUAL FUNCTION LABELING OF BIOMOLECULES BASED ON 
DSRED-MONOMER 
 
 
3.1 Introduction 
 
 Genetically encoded tags are powerful tools for protein research.  A variety of 
tags have been developed:  fluorescent probes for imaging and visualization, affinity tags 
for isolation and purification and epitope tags for immunological detections.  The ability 
to purify and visualize a protein of interest is of great importance to proteomics and 
biomolecular research [46-48].  Currently a number of affinity-based methods of protein 
purification are available, with either chemical or biological tags [49-51].  For efficient 
purification, either peptides or proteins are used as affinity tags [52-54].  However, a 
single affinity tag is now seldom used because of its limitations on purification 
effectiveness, but is rather used in tandem to achieve better results [55-57].  Additionally, 
for protein detection or localization, fluorescent probes such as fluorescent proteins, 
quantum dots, or fluorophores are fused to the protein as reporter tags [58-63].  Such 
systems require two separate tags to be fused to the target to accomplish protein 
purification and detection.  This double tagging limits the flexibility in terms of available 
termini for protein fusions, making the ability to use a single tag for both purposes 
desirable.  To address this issue we have designed a DsRed-Monomer fusion tag, which 
can be utilized to both purify a protein of interest and in fluorescence-based detection 
studies.   
Prior to this work only a few reports had been published demonstrating methods 
that offer dual functionality of tags.  Paramban et al. demonstrated the use of GFP for 
both localization and purification of a fused target protein.  In order to utilize GFP as a 
purification tag this group engineered a 6-His tag into the loop region of GFP, between
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Gln172 and Asp173 of the GFP [64].  The insertion of this histidine tag, however, lead to 
a 40 % loss of fluorescence but the remaining signal was sufficient for the detection of 
the fused target.  This work was expanded by Kobayashi et al. [65] who engineered a 
“multifunctional GFP” with an 8-His tag and a streptavidin-binding peptide, for affinity 
purification, and a c-Myc tag for immunological detection.  For this work the tags were 
engineered to be located between Asp173 and Gly174.  Similarly, dye and antidye-
antibody combinations have been used as dual function tags [66]. In a recent report, 
protein labeling was performed using the phosphopantetheinyltransferase (PPTase) to 
incorporate a stilbene reporter into a carrier protein fused to the target protein [67]. When 
the stilbene reporter binds to the anti-stillbene antibody, the fluorescence of the stilbene 
reporter group is turned on.  The stilbene labeled fusion protein can then be purified using 
the antibody bound column.  Such tags, however, present problems including high cost 
and low stability since they rely on immobilized antibodies. 
 The work presented in this chapter describes the use of site-specific tagging of a 
protein with DsRed-Monomer, for both purification and detection purposes.  In this work, 
we have demonstrated that DsRed-Monomer can be employed, based upon its inherent 
fluorescence and copper-binding properties, as an efficient purification and visualization 
tag.  As discussed in the preceding chapters, our group has reported on the natural, and 
selective, copper-binding affinity of DsRed-Monomer [17, 39].  We have utilized this 
copper-binding affinity to create an efficient, single-step, purification system for DsRed-
Monomer [16].  Here we have used DsRed-Monomer as an affinity tag to purify a fusion 
partner.  Furthermore, we show that this tag can also act as a reporter, utilizing DsRed-
Monomer’s natural fluorescence to perform bioassays.  Using such tagging systems 
offers a number of advantages including the flexibility to attach the target protein to 
either termini and to perform site-specific genetic encoding, and to the achievement of 
efficient detection due to DsRed-Monomers excitation and emission in the red region of 
the spectrum.  Protein-based affinity tags have also been shown to aid in the folding of 
the fusion partner, enhancing solubility, in comparison with peptide-based tags [52].  
Finally the use of copper-immobilized columns for purification offers an inexpensive, 
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stable and reusable platform, compared to the antibody-immobilized columns utilized by 
other systems. 
 To demonstrate the ability of DsRed-Monomer to function as a dual-function tag 
and to show its flexibility in genetic fusions of proteins, we constructed a fusion protein 
of DsRed-Monomer.  As a proof-of-concept study, a fusion protein between DsRed-
Monomer and a model protein calmodulin (CaM) was constructed through the N-
terminus of DsRed-Monomer.  CaM is a Ca2+-binding protein that is involved in the 
regulation of several cellular responses through its interaction with other proteins [68, 
69].  In the absence of Ca2+, the CaM has a collapsed conformation [70, 71].  In the 
presence of Ca2+, CaM changes its conformation from a collapsed to a “dumbbell” 
configuration exposing its hydrophobic region that acts as a docking area for target 
peptides, proteins, and the tricyclic phenothiazene class of compounds [70, 72-75].  This 
CaM-DsRed-Monomer fusion protein was expressed in E. coli and purified using a 
copper-immobilized column.  It was further employed as a fluorescent tag to evaluate the 
binding of a known CaM ligand, chlorpromazine, to this fusion protein [74, 75].  
Furthermore, we demonstrated that this DsRed-Monomer tag could be separated from its 
fusion partner, CaM, by simply inserting a protease cleavage between the DsRed-
Monomer and CaM.   
 
 
3.2 Materials and Methods 
 
3.2.1 Construction of Calmodulin-DsRed-Monomer Fusions 
 
 The PCR primers were designed to introduce the sequences for the restriction 
enzymes, SphI and XmaI on the CaM gene (Table 5).  The plasmid pVUC-1 was used as 
a template.  The CaM gene obtained after PCR and the pDsRed-Monomer were digested 
with SphI and XmaI followed by ligation of the CaM gene into pDsRed-Monomer 
plasmid to obtain pSKD104 (Figure 15).  The plasmid pSKD104 was transformed into E. 
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coli ER2566 strain.  The colonies were picked and miniprep was performed.  DNA 
sequencing was utilized to determine the sequence of the fusion protein.    
 
Figure 15:  CaM-DsRed-Monomer plasmid map, ~3.8 kb 
 
Table 5:  PCR primers used to create Calmodulin-DsRed-Monomer fusion   Primer  Sequence 
CaMSphI  ATATATGCATGCGATGGCTGATCAGCTGACTGACGAGCAG 
CaMXmaI‐Rev  ATATATCCCGGGCCTTAGCCATCATAACCTGAAACGAACTC 
CaMXmaITEV‐Rev  CCCGGGCCCCCTGGAAGTACAGGTTTTCCTTAGCCATCATAACCTGAACG    To construct the fusion gene, incorporating the TEV protease cleavage site 
between the calmodulin and DsRed-Monomer genes, the same forward primers, 
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restriction enzymes, and molecular biology techniques were used as above for the CaM-
DsRed-Monomer fusion.  However, a new reverse primer was designed (Table 5) which 
incorporated the TEV cleavage site, Glu-Asn-Leu-Tyr-Phe-Gln-Gly, before the XmaI 
restriction site.  The DNA coding for TEV cleavage site is in italics and the DNA coding 
for XmaI is underlined.  The PCR product was ligated into pDsRed-Monomer plasmid to 
obtain the plasmid pSKD104-TEV.  This plasmid was transformed into E. coli JM107 
strain.       
 
3.2.2 Expression and Purification of Calmodulin-DsRed-Monomer Fusions 
 
 The fusion proteins of DsRed-Monomer were expressed in JM107 E. coli as 
previously described in Chapter 2 [76].  Briefly, 5 mL cultures of LB broth (containing 
100 µg/mL ampicillin) with the prepared plasmids pSKD104 and pSKD104-TEV in E. 
coli were grown overnight.  These cultures were transferred to 200 mL samples and 
grown to an OD420 of 0.5.  Protein expression was induced by the addition of IPTG (0.5 
mM), and grown overnight at 37 °C for CaM-DsRed-Monomer and at 30 °C for CaM-
TEV-DsRed-Monomer.  The cells were then collected by centrifugation at 4 °C, 4000 x 
g, for 15 min and sonicated using 20 s on 20 s off for 5 min.  The crude fusion proteins 
were collected by centrifugation at room temperature, 4000 x g for 30 min.  The crude 
fusion proteins were purified as described previously in Chapter 2 [77], utilizing a copper 
charged metal affinity column.  Purity and concentration were found by SDS-PAGE gel 
electrophoresis and Bradford assay, respectively.  
 
3.2.3 Protease Cleavage of Calmodulin from DsRed-Monomer 
 
 Promega ProTEV protease was used according to the manufacturer’s 
recommendations with the supplied buffer to cleave the CaM from the purified CaM-
TEV-DsRed-Monomer fusion protein.  The reaction was allowed to continue for 24 h at 
37 °C.  Complete cleavage of CaM was verified by SDS-PAGE gel electrophoresis, with 
Coomassie staining. 
  41 
 
3.2.4 Spectral Analysis of Fusion Protein 
 
 The fluorescence spectrum of CaM-DsRed-Monomer was collected.  A volume of 
200 µL of 1.0 µM CaM-DsRed-Monomer was placed into the well of a microtiter plate 
and the excitation and emission scans of the protein recorded.  These scans were 
collected at room temperature using a Cary Eclipse fluorescence spectrophotometer. 
 
3.2.5 Calmodulin Ligand-Binding Study 
 
 Initially, a dilution study was prepared for the CaM-DsRed-Monomer.  Standard 
solutions of CaM-DsRed-Monomer fusion protein were prepared by serially diluting the 
stock solution of the protein in assay buffer 1 (30 mM Tris containing 10 mM calcium, 
pH 7.2). A volume of 100 µL of these solutions was mixed with 100 µL of assay buffer 
1, placed in a microtiter plate, and the fluorescence intensity measured using an 
excitation maximum wavelength of 556 nm and emission wavelength maximum of 597 
nm.  All fluorescence intensities were obtained in triplicate. 
 A Dose-Response curve was generated for the fusion protein in the presence of 
chlorpromazine from the tricyclic phenothiazene class of drugs.  Different concentrations 
of chlorpromazine were prepared by diluting in assay buffer 1.  A volume of 100 µL of 
1.0 µM CaM-DsRed-Monomer was mixed with 100 µL of chlorpromazine, at different 
concentrations.  The fluorescence intensity was monitored corresponding to DsRed-
Monomer excitation/emission wavelength.  A control study was performed using DsRed-
Monomer and chlorpromazine.  In another control study, solutions of varying 
concentrations of chlorpromazine (1 x 10-3 to 1 x 10-6 M) were excited at 556 nm and the 
fluorescence emission monitored at 597 nm. 
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3.3 Results and Discussion 
 
The results obtained from this study demonstrate the dual application of DsRed-
Monomer.  Reporter proteins, such as DsRed, are commonly fused to a target protein for 
fluorescence-based bioassay development.  However, if the same reporter protein can 
also function as an affinity purification tag, then this will reduce the assay development 
time and simplify the assay development process.  To demonstrate the versatility of 
DsRed-Monomer as a dual-function tag we have selected a calcium-binding, biologically 
relevant protein, calmodulin, as the fusion partner for this proof-of-concept study. 
The DNA encoding for the calmodulin gene was fused to the gene coding for 
DsRed-Monomer using genetic engineering tools to construct a genetic fusion.  Plasmid 
pSKD104 and pSKD104-TEV containing the fusion gene, and the fusion gene with a 
TEV protease cleavage site between the CaM and the DsRed-Monomer were transformed 
into E. coli cells and expressed.  The fusion proteins were then purified using a copper-
immobilized column, utilizing DsRed-Monomer as an affinity tag.  Briefly, the crude 
fusion proteins were bound, via DsRed-Monomer’s natural copper affinity, to 
immobilized copper ions on a metal affinity column.  The purified fusion protein 
fractions were collected after wash steps by passing through an elution buffer, containing 
imidazole.  The elution of the purified fusion proteins was monitored by the pink 
coloration of DsRed-Monomer, and by measuring the fluorescence of the collected 
fragments.  The purity of the fusion proteins was verified by SDS-PAGE gel 
electrophoresis using Coomassie staining (Figure 16).  The single band, at 41.5 kDa, 
demonstrates the efficiency of the CaM-DsRed-Monomer purification.  We also 
performed an expression study to compare the effect of fusion of calmodulin to DsRed-
Monomer on the expression yield.  For this study we expressed wild-type calmodulin and 
CaM-DsRed-Monomer proteins under identical conditions.  The conditions followed 
were the same as those used to express the fusion protein, described above.  SDS-PAGE 
gel electrophoresis was performed that showed similar expression yields for calmodulin 
and CaM-DsRed-Monomer proteins (Figure 17).  Additionally, the total protein yield for 
the two proteins was similar, as seen on this gel.  For both of these proteins identical 
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expression and sonication protocols and volumes were used for both expressions.  These 
observations indicate that the fusion of the target protein to DsRed-Monomer does not 
affect the expression of the target protein.  The concentration of the purified protein was 
determined using Bradford assay.  Percent recovery of the purified protein was estimated 
by passing a known quantity of purified fusion protein through the copper-immobilized 
column.  The purification procedure was followed and the concentration of the eluted 
protein determined.  The amount of eluted protein was compared to the amount of the 
protein initially loaded onto the column.  The recovered protein was calculated to be ~96 
% for the CaM-DsRed-Monomer fusion.  
 
Figure 16:  SDS-PAGE gel of CaM-DsRed-Monomer fusion protein molecular weight 
protein marker (lane 1), crude (lane 2), and purified (lane 3) CaM-DsRed-Monomer  
  44 
 
Figure 17:  SDS-PAGE gel of expression yield comparison of CaM-DsRed-Monomer 
fusion protein and wild-type CaM, both expressed in E. coli  
To demonstrate that the target protein can be separated after purification, from 
DsRed-Monomer, we incorporated a TEV protease cleavage site between the CaM and 
the DsRed-Monomer genes.  The fusion protein was again purified on a copper 
immobilized column employing DsRed-Monomer as an affinity tag.  The DsRed-
Monomer was cleaved off easily and completely from the CaM-TEV recognition site-
DsRed-Monomer fusion protein within a 24 h time period.  This was verified, again, by 
SDS-PAGE gel electrophoresis (Figure 18), this gel shows two bands corresponding to 
calmodulin (~15 kDa) and DsRed-Monomer (~27 kDa).  Therefore, it is reasonable to 
conclude that although DsRed-Monomer is a large affinity tag it can be efficiently 
separated from the target protein if desired.  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Figure 18:  SDS-PAGE gel of protease cleavage of DsRed-Monomer from CaM-TEV 
recognition site-DsRed-Monomer, molecular weight protein marker (lane 1), separated 
CaM and DsRed-Monomer proteins (lane 2)  
Although variants of DsRed have been employed as fusion tags in other studies, 
there have previously been no published reports on fusions of DsRed-Monomer.  
Therefore, the spectral characteristics of the fusion protein were evaluated to determine 
any effect of protein fusion on the DsRed-Monomer protein structure and fluorescence 
emission (Table 6).  Fluorescence excitation and emission scans were performed for the 
CaM-DsRed-Monomer fusion protein, with an observed excitation and emission 
wavelength maximum of 556 nm and 597 nm, respectively.  This observed fluorescence 
excitation and emission is indicative of DsRed-Monomer [16].  UV-visible absorbance 
spectrum of the fusion protein showed two peaks 480 nm and 556 nm, again, these are 
the representative peaks observed for DsRed-Monomer [77].  A comparison of the 
spectral properties of the fusion protein with DsRed-Monomer showed no effect of 
protein fusion on the DsRed-Monomer fluorescence activity.  These studies indicate that 
the fusion of a protein to DsRed-Monomer does not affect the fluorescence excitation or 
emission wavelength maxima of the protein. 
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Table 6:  Characteristics of DsRed-Monomer and the CaM fusion protein     λexcitation (nm)   λemission (nm)  Absorbance Max (nm)  ε (M‐1cm‐1) DsRed‐Monomer  556  597  480, 556  35,000 
CaM‐DsRed‐Monomer  556  597  480, 556  59,000  
The purification and spectroscopic analysis of the CaM-DsRed-Monomer fusion 
protein showed that a protein of interest could be fused to the DsRed-Monomer without 
affecting its copper-binding affinity, fluorescence or absorbance.  This should prove 
useful in the visualization of fusion proteins, followed by their isolation.  Furthermore, 
we wanted to demonstrate that a fusion with DsRed-Monomer could also be utilized in 
the optical detection of the interactions of a fused target protein with its ligands.  In that 
respect, calmodulin is a well-studied protein with known ligands that are commercially 
available: therefore, we decided to study binding of CaM ligands to CaM-DsRed-
Monomer fusion protein.  This can be performed in two ways.  The CaM-DsRed-
Monomer fusion protein can be genetically encoded to study calmodulin interacting 
proteins or ligands in vivo, or the isolated fusion protein can be used to study calmodulin 
interacting molecules in vitro.  It has been reported by other groups that fusions between 
GFP and calmodulin can be utilized in screening ligands that bind calmodulin [32, 33, 
78] in solution-phase assay.  On the basis of this, we performed a solution-based study by 
mixing CaM-DsRed-Monomer and a known representative CaM ligand, chlorpromazine.  
The addition of chlorpromazine resulted in a quenching of CaM-DsRed-Monomer 
fluorescence.  This change in fluorescence can be attributed to the conformational change 
that occurs in calmodulin upon binding its ligand.  It has been hypothesized that the 
conformational change in calmodulin may lead to a change in the microenvironment of 
the fused fluorescent proteins affecting their fluorescence output.  A dose-response curve 
was generated for this assay by varying the amount of chlorpromazine added to the CaM-
DsRed-Monomer fusion and relating this concentration to the change in fluorescence 
intensity (Figure 19).  A detection limit of 5 x 10-6 M was obtained for chlorpromazine, 
which is comparable to that achieved with other reported fluorescence-based assays for 
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chlorpromazine [73, 78].  A control study was performed, by adding chlorpromazine to 
DsRed-Monomer protein, which did not result in fluorescence quenching (data not 
shown).  In another control study, we evaluated the effect of fluorescence excitation at 
556 nm on chlorpromazine, which is inherently fluorescent.  For this study, solutions of 
varying concentrations of chlorpromazine were excited at 556 nm, and the resulting 
emission monitored at 597 nm.  The fluorescence intensity obtained from these samples 
was the same as for the buffer blank, demonstrating no effect of fluorescence excitation 
on chlorpromazine.  Overall, the study performed shows that the binding between 
calmodulin and its ligand can be monitored using the fluorescence of DsRed-Monomer.  
Furthermore, the observed fluorescence quenching is due to the specific binding of 
chlorpromazine to calmodulin.  We hypothesize that binding of other phenothiazene-
based CaM ligands would yield similar results and could be evaluated if desired.  It 
should be noted that the fluorescence change observed upon binding of ligands to CaM 
might not be universally applicable to other target protein-ligand pairs.  Nevertheless, the 
fluorescence of DsRed-Monomer could still be used in the evaluation of target-protein 
ligand pair using solid-phase competitive assay techniques.  
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Figure 19:  Dose-response curve for chlorpromazine generated by monitoring 
fluorescence change upon the addition of different concentrations of chlorpromazine to 
CaM-DsRed-Monomer fusion protein.  Fluorescence was measured using 556 nm 
emission wavelength maximum   
3.4 Conclusion 
 
 The work presented in this chapter, has demonstrated that DsRed-Monomer can 
be utilized as both an affinity and reporter tag.  DsRed-Monomer offers a unique 
collection of properties, which allow its use in these roles, for both in vivo and in vitro 
protein analysis.  We believe that in the future new vectors based on DsRed-Monomer 
could be designed that allows the insertion of any protein.  The recombinant proteins 
produced could then be expressed in different organisms, monitored optically, purified, 
and employed in assay development.  Further, if desired, protease cleavage sites can be 
incorporated into the fusion protein designs to isolate the target protein following 
purification.  We did not experience any problems with the protease cleavage between 
DsRed-Monomer and the target protein.  This technique is well developed and has been 
performed with DsRed previously [79-82].  Additionally, the DsRed-Tetramer/GFP pair 
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has been employed to design fluorescence resonance energy transfer assays for the 
detection of protease activity by inserting substrate for the protease between the genes of 
the two fluorescent proteins [80-82].  This is the first report of the fusion of a protein to 
DsRed-Monomer and its use as a label in the detection of protein-ligand binding.  
Through the work presented here we envision that DsRed-Monomer will, in future, be 
employed as a tag inserted directly into cells, expanding its utility in such biomolecular 
research.   
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CHAPTER 4. UTILIZING DSRED-MONOMER AS AN AFFINITY TAG TO 
ISOLATE PROTEIN-PROTEIN/PEPTIDE COMPLEXES 
 
 
4.1 Introduction 
 
 Protein complexes mediate the majority of cellular processes.  The ability to 
localize and isolate such complexes may provide key insights into protein functions. 
Purification of protein complexes, in combination with mass spectrometry, allows 
identification of interacting partners, and is becoming an important tool to define 
relationships between proteins [83, 84].  Since, currently, as little as 100 fmol of a protein 
can be evaluated by mass spectrometry, rapid characterization of a protein present in a 
complex mixture is easily accomplished.  This characterization, however, requires that 
the protein complex be easily and selectively isolated in a reasonable quantity; hence 
protein characterization is frequently limited by the ability to isolate protein complexes of 
interest [85].  In this work we present a proof-of-concept study, which overcomes some 
of these challenges, by utilizing the copper-binding properties of DsRed-Monomer.  
Fusions of DsRed-Monomer were used to isolate protein-peptide and protein-protein 
complexes. 
Affinity tags have been demonstrated as efficient tools for purifying protein 
complexes [86].  Additionally, the mild conditions used to elute these tags make them 
useful tools for purifying protein complexes, under native conditions.  Affinity tags allow 
a diverse group of proteins and protein complexes to be purified using general and simple 
protocols.  This simplicity and native condition elution, in contrast to highly customized 
procedures associated with conventional chromatography generally used for proteomics 
and structural genomics, are their primary advantages.  Most of the commonly used 
protein and peptide affinity tags have been developed within the last 20 years and can be
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categorized depending on the nature of the affinity tag and its target.  Affinity tags have 
been designed, which utilize peptide or protein fusions, to bind small molecules on a 
solid support or chromatography resin [87].  Further affinity tags have utilized antibodies 
on a chromatography resin to bind a specific peptide [86].  
A number of affinity purification approaches have been developed, including 
immunoaffinity, epitope tagging, and glutathione S-transferase (GST) pulldown.  Among 
these, tandem affinity tag purification (TAP) has recently become the focus of native 
purification for protein complexes [56, 85, 88].  This strategy allows for fast purification 
of protein complexes with high yield.  The TAP tag method involves the fusion of the tag 
to a target protein and the introduction of this construct into a host cell [85].  The TAP 
tag is composed of two IgG binding domains of Staphylococcus aureus protein A (ProtA) 
and a calmodulin binding peptide (CBP) with a TEV protease cleavage site between the 
IgG and CBP [85].  These TAP tags have been designed for both the N- and C-terminal 
fusion.  This method of affinity purification has been optimized for the purification of a 
number of different proteins and protein complexes.  
Fluorescent proteins have been widely applied for in vivo visualization of proteins 
however, isolation studies using fluorescent proteins have largely been ignored.  GFP has 
been used to genomically tag more than 4000 proteins for large-scale analysis of protein 
localization in Saccharomyces cerevisiae [89].  GFP variants with an incorporated 
histidine tag have demonstrated the potential to serve both as a visualization and isolation 
tags.  Such GFP fusions with a poly histidine tag have recently been utilized for isolation 
studies [64, 65].  Studies have also been reported which utilized GFP in immunoaffinity 
purifications [90-96].  Such work with GFP has further led to the design of GFP fusion 
tags that can visualize proteins in live cells and capture their interactions via 
immunoaffinity purification on magnetic beads coated with anti-GFP antibodies [97].   
These immunoaffinity methods, however, rely on antibody-coated beads; such strategies 
present unique problems, including the high cost and limited stability of these antibodies.          
Based on previous work in our laboratory [16], we believe that DsRed-
Monomer’s natural copper-binding affinity could provide an ideal partner for affinity 
purification of an interacting protein or peptide complex.  This method offers advantages 
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over previous methods since it requires only one purification step, making it a faster 
method.  Fusions of DsRed-Monomer have also been shown to retain full fluorescence 
emission, compared to GFP tags with an incorporated poly His tag.  Additionally, this 
method uses a stable and inexpensive affinity column.  In this chapter, we have 
demonstrated the use of fusions of DsRed-Monomer to isolate and purify a protein 
complex, utilizing the natural copper-binding affinity of DsRed-Monomer (Figure 20).  
Two fusions of DsRed-Monomer were used for this purification strategy, M13-DsRed-
Monomer and CaM-TEV-DsRed-Monomer.  The first of these fusions, M13-DsRed-
Monomer, utilized the calmodulin-binding domain of skeletal muscle myosin light chain 
kinase (skMLCK) (residues 577-602), M13, fused to the N-terminus of DsRed-Monomer.  
This fusion was then used to isolate and purify CaM from a crude cellular sample.  For 
this work crude calmodulin was combined with the crude M13-DsRed-Monomer fusion 
protein and allowed to bind.  This complex was then isolated, via affinity 
chromatography, on a copper charged metal affinity column.   
 
 
Figure 20:  Schematic of protein complex isolation strategy 
 
Additionally, we further utilized the CaM-TEV-DsRed-Monomer fusion, 
previously created and discussed in Chapter 3 [76], to isolate a CaM interacting protein, 
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caldesmon.  Caldesmon is primarily an F-actin binding protein, isolated from smooth 
muscle cells.  Such F-actin binding proteins are believed to be responsible for both the 
functional organization of microfilaments and their reorganization during normal 
functioning of cells [98].  The C-terminal region of this protein is also a primary binding 
site for the Ca2+-CaM complex [99].  As seen for the CaM binding discussed in the 
previous chapter, the binding of caldesmon to CaM is also calcium dependent.  The 
copper-binding affinity of DsRed-Monomer was used, again, to isolate this CaM-
caldesmon complex.  We have used the M13-DsRed-Monomer and CaM-TEV-DsRed-
Monomer fusions to demonstrate the ability of DsRed-Monomer to isolate and purify 
interacting protein-protein and protein-peptide complexes.     
 
 
4.2 Materials and Methods 
 
4.2.1 M13-DsRed-Monomer and CaM-TEV-DsRed-Monomer Plasmid Construction 
 
The plasmid pDsRed-Monomer was used as a template for the PCR reaction; 
primers were designed that encode the DNA sequence of the M13 peptide.  Using four 
consecutive PCR reactions, the DNA sequence for the peptide, with a 5 amino acid linker 
(GGSGG), was inserted at the N-terminus of the DsRed-Monomer sequence present in 
the plasmid.  These primers are displayed in Table 7.  The product of each PCR was run 
on an agarose gel and the band of interest extracted for the subsequent PCR step.  A final 
PCR was run to correct the reading frame of the DNA.  This final product, plasmid 
pSKD105, was digested with Dpn1 for 1 h at 37 °C and transformed into ER2566 E. coli.  
The CaM-TEV-DsRed-Monomer fusion, plasmid pSKD104-TEV, was prepared as 
described in Chapter 3 [76]. 
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Table 7:  Primers for the insertion of the M13 peptide at the N-terminus of DsRed-
Monomer Primer   Sequence 
Forward Primer PCR1  GCATTAGGTAGTGGTGGTCCCCGGGTACCGGTCGCC Forward Primer PCR2  AATAGATTTAAAAAAATTAGTAGTAGTGGAGCATTAGGTGGTAGTGGT Forward Primer PCR3  AGATGGAAAAAAAATTTTATTGCAGTAAGTGCAGCAAATAGATTTAAAAAAATT Forward Primer PCR4  ATATATAAGCTTGGTGGTAGTGGTGGTAAAAGAAGATGGAAAAAAAATTTT Reverse Primer PCRRev  TATTATTATGAATTCGCTCTACTGGGAGCCGGAGTGGCGGGC Forward Primer PCRcorrection  GACCATGATTACGCCAAGCTTGGGTGGTAGTGGTGGTAAAAGAAGATGG Reverse Primer PCRcorrectionRev  CCATCTTCTTTTACCACCACTACCACCCAAGCTTGGCGTAATCATGGTC  
4.2.2 Fusion Protein Expression 
 
 The cells containing the plasmids (pSKD104-TEV, pSKD105, and pVUC-1) that 
encode for the DsRed-Monomer fusion proteins, and spinach CaM, were grown as 
previously described in LB containing ampicillin with shaking at 250 rpm at 37 °C to an 
OD600 of 0.5.  The protein expression was induced using IPTG (0.5 mM) and the cells 
were allowed to grow for an additional 24 h at room temperature for the spinach CaM, 
and 5 h at 37 °C for the DsRed-Monomer fusions.  The cells were harvested by 
centrifugation and the pellets resuspended in TBS (30 mM Tris, 300 mM NaCl, with 10 
mM Ca2+, pH 7.2) and sonicated using 20 s on and 15 s off for 3 min.  The crude proteins 
were obtained by centrifugation (4000 x g for 30 min) at room temperature.  The DsRed-
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Monomer fusions were purified for spectroscopic studies using our previously developed 
copper purification method, described in Chapter 2 [16].     
 
4.2.3 Caldesmon Extraction 
 
 Crude Caldesmon was prepared from fresh chicken gizzards [98].  A 20 g sample 
of trimmed smooth muscle from fresh chicken gizzards was collected and washed in cold 
water, containing 0.25 mM phenylmethylsulfonyl fluoride.  The washed chicken gizzards 
were minced and suspended in six volumes of extraction buffer (0.3 M KCl, 1 mM 
EGTA, 0.5 mM MgCl2, 0.25 mM phenylmethylsulfonyl fluoride, 50 mM imidazole-HCl, 
pH 6.9) at 4 °C, and blended at high speed until finely homogenized.  The slurry was then 
heated in boiling water for five min, at least 2 min at 90 °C, and chilled on ice.  The 
slurry was then centrifuged for 30 min at 47,000 x g, and the solid discarded.  
Ammonium sulfate was added to the supernatant to a concentration of 30 %, and the 
precipitate removed by centrifugation.  Ammonium sulfate was again added to the 
supernatant to a final concentration of 50 %, and the precipitate collected by 
centrifugation.  This precipitate was dissolved in 5 mL of buffer A (0.1 M NaCl, 0.1 mM 
EGTA, 0.1 mM DTT, 10 mM imidazole-HCl, pH 7.0).  The crude caldesmon was run on 
an SDS-PAGE gel and buffer exchanged into TBS buffer (30 mM Tris, 300 mM NaCl) 
and then into Tris with calcium (30 mM Tris, 300 mM NaCl, 10 mM CaCl2), for binding 
studies with DsRed-Monomer fusion protein.   
 
4.2.4 Binding Studies Utilizing DsRed-Monomer Fusion Proteins 
 
 Crude M13-DsRed-Monomer, 2 mL, was combined with 2 mL crude CaM and 
mixed for 1 h at room temperature.  The crude mixture was passed through a syringe 
filter onto a copper charged metal affinity column, and rotated for 1 h to allow the 
DsRed-Monomer to bind to the immobilized copper.  The column was washed with 
multiple column volumes of TBS buffer (up to 10 mL).  A volume of 5 – 10 mL of TBS 
buffer with increasing concentrations of imidazole (1 – 4 mM) were used to wash the 
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column.  The CaM-M13-DsRed-Monomer complex was eluted with TBS containing 5 
mM imidazole, until the entire red color band had been collected.  A similar protocol was 
utilized to isolate the caldesmon-CaM-TEV-DsRed-Monomer complex.  For this 
complex 500 µL of concentrated crude caldesmon, in TBS buffer with calcium, was 
combined with 500 µL CaM-TEV-DsRed-Monomer fusion, diluted to 5 mL with TBS 
buffer with calcium and mixed overnight at 4 °C.  This complex was applied to a copper 
charged metal affinity column, rotated for 1 h and washed with increasing concentration 
of imidazole-containing TBS buffer with calcium.  Each wash used a volume of 5 – 7 mL 
of buffer.  The Caldesmon-CaM-TEV-DsRed-Monomer complex was eluted with TBS 
buffer containing 5 mM imidazole.  
 
4.2.5 Spectroscopic Analysis of M13-DsRed-Monomer Fusion 
 
The UV-visible and fluorescence spectra of the M13-DsRed-Monomer fusion 
were collected as previously described for CaM-TEV-DsRed-Monomer [76].  Briefly, A 
volume of 1 mL of (0.1 µM) the M13-DsRed-Monomer fusion was placed in a cuvette, 
and the absorption spectra of the fusion recorded at room temperature, using an Agilent 
8453 UV-visible spectrometer from Agilent Technologies (Santa Clara, CA).  For the 
fluorescence spectra, a 200 µL volume of the fusion protein was placed in a microtiter 
plate and the excitation and emission spectra obtained at room temperature using a Cary 
Eclipse Fluorescence Microtiter Plate Reader from Varian Inc. (Walnut Creek, CA).  The 
absorbance, excitation, and emission wavelength of the CaM-TEV-DsRed-Monomer 
fusion protein are tabulated in Table 6, seen in Chapter 3 [76].   
 
4.2.6 SDS-PAGE and Blot Analysis of Eluted Complexes 
 
 The purified CaM-M13-DsRed-Monomer and caldesmon-CaM-TEV-DsRed-
Monomer complexes were run on an SDS-PAGE gel.  For the dot blot analysis a volume 
of 1.5 µL of the purified CaM-M13-DsRed-Monomer complex was spotted onto a piece 
of nitrocellulose, dried, and incubated for 1 h, in Tris/Ca2+ buffer with 0.5 % skim milk, 
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at room temperature.  The nitrocellulose was then washed three times for 5 min in PBS 
buffer, and incubated with the Tris/Ca2+ buffer containing a 1:500 dilution of a primary 
anti-CaM antibody for at least 30 min.  This was again washed three times for 5 min with 
Tris/Ca2+ buffer and incubated for a further hour with a 1:5000 dilution of the secondary 
antibody.  The nitrocellulose was again dried and then incubated with a horseradish 
peroxidase substrate.  The same protocol was used for the caldesmon-CaM-TEV-DsRed-
Monomer complex, utilizing an anti-caldesmon primary antibody.  The Caldesmon-CaM-
TEV-DsRed-Monomer complex was further subjected to western-blotting.  The complex 
was run on a 10 % SDS-PAGE gel and transferred to a nitrocellulose membrane using 
electrophoretic blotting, 20 V, 100 mA for 4.5 h, in TOWBIN buffer (25 mM Tris, 192 
mM glycine, 20 % (vol/vol) methanol, pH 8.3).  The membrane was blocked for 1 h in 
the Tris/Ca2+ buffer with 5 % powered milk, and incubated overnight, at 4 °C, with the 
primary anti-caldesmon antibody (1:5000 dilution).  The membrane was washed three 
times for 10 min with the Tris/Ca2+ buffer and incubated for a further hour with a 1:5000 
dilution of the secondary antibody.  The blot was, again, visualized with horseradish 
peroxidase substrate. 
 
 
4.3 Results and Discussion 
 
 The work presented in this chapter demonstrates the use of DsRed-Monomer as 
an affinity tag for the isolation of protein-peptide and protein-protein complexes.  DsRed-
Monomer’s natural copper-binding affinity has been utilized to purify itself, as well as 
genetically fused proteins and peptides, as discussed in Chapter 3 and in previous reports 
[16].  The fusions of DsRed-Monomer prepared here have allowed for the isolation of 
interacting protein complexes, again utilizing this natural copper-binding affinity.  We 
have isolated a protein-peptide complex, CaM-M13, and a protein-protein complex, 
caldesmon-CaM, from a crude cellular extract using DsRed-Monomer as an affinity tag 
(Figure 20). 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 The M13-DsRed-Monomer fusion gene was prepared by PCR technique as 
described in the methods section.  This gene was evaluated via DNA sequencing to verify 
the presence of the M13 peptide and the reading frame of the gene.  This was further 
confirmed by the lack of red fluorescence seen for the expressed protein.  A shift in the 
M13-DsRed-Monomer reading frame was observed due to wrong primer design.  To 
correct this error another primer was designed.  The sequencing results of the new 
plasmid showed that the M13 DNA sequence and the DsRed-Monomer gene were both 
present and in the correct reading frame.  This gene was transformed and expressed in E. 
coli.  The M13-DsRed-Monomer fusion protein was initially purified on a copper 
immobilized column and run on an SDS-PAGE gel to verify its purity (Figure 21).  The 
spectral characteristics of the purified fusion protein were monitored.  The UV-vis 
absorbance spectra, of M13-DsRed-Monomer, yielded results comparable to those seen 
for native DsRed-Monomer, with peaks at ~480 and ~556 nm.  Additionally the 
excitation and emission wavelength maxima obtained for the purified M13-DsRed-
Monomer, 556 and 597 nm, are the same as that reported for DsRed-Monomer previously 
in this work.  The CaM-TEV-DsRed-Monomer fusion was prepared, expressed, purified, 
and spectrally evaluated as described in the previous chapter [76].  As previously 
reported this DsRed-Monomer fusion showed the same absorbance and excitation and 
emission wavelength maxima as DsRed-Monomer (Table 8).  While these two DsRed-
Monomer fusions were purified for spectral analysis, crude fusion proteins were used for 
the subsequent binding studies.   
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Figure 21:  SDS-PAGE gel of purified M13-DsRed-Monomer, (lane 1) molecular weight 
protein marker, (lane 2) crude M13-DsRed-Monomer, molecular weight marker (lane 3), 
pure M13-DsRed-Monomer (lane 4) 
 
Table 8:  Characteristics of DsRed-Monomer and the CaM and M13 fusions   λexcitation (nm)   λemission (nm)  Absorbance Max (nm) DsRed‐Monomer  556  597  480, 556 CaM‐TEV‐DsRed‐Monomer  556  597  480, 556 M13‐DsRed‐Monomer  556  597  480, 556  
The spinach CaM encoded into the pVUC-1 plasmid was expressed in E. coli and 
run on an SDS-PAGE gel, a strong band was observed at ~15 kDa, indicative of the crude 
CaM (Figure 22).  Initial control studies were done to determine if any copper-binding 
affinity existed for the CaM alone.  Crude CaM was applied to an immobilized copper 
column, allowed to bind to the column for 1 h and washed with TBS buffer, containing 
no imidazole.  Further washes were done with increasing imidazole concentrations (1 – 5 
mM) and the whole series run on an SDS-PAGE gel.  This gel showed that the CaM 
eluted in the initial wash step, prior to the addition of the imidazole, demonstrating that 
CaM has no copper-binding affinity.  To isolate the CaM-M13-DsRed-Monomer 
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complex, 2 mL of both the crude spinach CaM and the M13-DsRed-Monomer fusion was 
mixed for at least an hour at room temperature.  Since this CaM-M13 interaction is 
calcium dependent, all buffers used for the purification contained 10 mM CaCl2.  The 
binding time for the CaM-M13 complex formation was chosen based on a number of 
studies, these studies allowed an optimal time to be determined.  Binding the CaM to the 
M13-DsRed-Monomer for less than 1 hour resulted in poor isolation of the CaM-M13 
complex, whereas longer than 1 hour showed no noticeable improvement.  The binding 
kinetics between the CaM protein and the M13 peptide would be much faster in an 
optimal cellular environment.  However, in our studies performed in cellular extract, we 
believe that the environment is not ideal for binding, which may have resulted in the 
longer binding time seen for these studies.  The crude complex mixture was applied to a 
copper charged metal affinity column, and bound for at least 1 h at room temperature.  
The column was washed with multiple column volumes of TBS buffer, containing 
calcium.  Further washes were done with TBS with increasing concentrations of 
imidazole (from 1 to 4 mM).  To elute the purified complex, 2 to 5 mL of a TBS buffer 
with 5 mM imidazole were passed through the column.  Since the DsRed-Monomer has a 
vibrant red color the eluted complex was easily observed as it flowed off the column.   
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Figure 22:  SDS-PAGE gel of crude fusion protein and crude CaM, molecular weight 
protein marker (Lane 1), crude CaM M13-DsRed-Monomer complex (Lane 2), and crude 
CaM (Lane 3) 
 
The purity of the isolated complex was evaluated by SDS-PAGE gel 
electrophoresis, which yielded two bands, one at ~15 kDa, consistent with spinach CaM 
and one at ~29 kDa coinciding with M13-DsRed-Monomer (Figure 23).  The eluted 
complex was further analyzed by dot blot assay, to confirm that the isolated protein is 
indeed CaM.  A 1.5 µL sample of the purified complex, along with a 1.5 µL sample of 
the collected flow through from the initial wash steps of the purification, was spotted 
onto a nitrocellulose membrane, and incubated with an anti-CaM primary antibody.  This 
was then incubated with a secondary antibody and then with a horseradish peroxidase.  A 
strong blue color was observed within minutes of the addition of the peroxidase substrate, 
indicating the presence of CaM within the complex on the spot (Figure 24).  The flow 
through from the initial wash steps of the purification was also blotted to determine if any 
of the CaM was washing off the column prior to its elution as the complex with M13-
DsRed-Monomer.     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Figure 23:  SDS-PAGE gel of isolated CaM-M13-DsRed-Monomer complex (lane 1), 
molecular weight protein marker (lane 2)  
  
Figure 24:  Dot blot assay of isolated CaM-M13-DsRed-Monomer (right panel) collected 
flow through from the initial wash step of the purification (left panel)    Using a similar protocol, the caldesmon-CaM-TEV-DsRed-Monomer complex 
was also isolated.  For this study, crude caldesmon was extracted from smooth muscle, 
obtained from fresh chicken gizzards, and run on an SDS-PAGE gel (Figure 25).  A 
control study was also conducted with the caldesmon protein to determine if it bound to 
the copper column in the absence of the CaM-TEV-DsRed-Monomer.  This protein also 
eluted in the initial wash step, indicating that caldesmon does not bind to the copper 
column in the absence of CaM-DsRed-Monomer.  To isolate the caldesmon-CaM 
complex, both crude proteins, caldesmon and CaM-TEV-DsRed-Monomer, were 
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combined, mixed overnight at 4 °C, and applied to a copper charged metal affinity 
column.  As described previously, this binding time was determined by a series of time 
studies, which determined the optimal time required for the binding of the caldesmon-
CaM complex.  The complex was allowed to bind to the column for at least 1 hour and 
washed with multiple column volumes of TBS buffer.  All TBS buffers used for this 
purification contained 10 mM CaCl2, again, since the interaction between caldesmon and 
CaM is also calcium dependent.  The column was washed with TBS buffer with 
increasing concentrations of imidazole (from 1 to 4 mM).  The complex was eluted with 
TBS buffer containing 5 mM imidazole.  The color of the DsRed-Monomer was again 
used to indicate when the complex had fully eluted.  The collected elution was run on an 
SDS-PAGE gel and evaluated via dot blot as described for the CaM-M13-DsRed-
Monomer (Figure 26).  Although the caldesmon selected for this study was isolated from 
chicken gizzards, we expected it to bind to the spinach calmodulin.  Calmodulin proteins, 
from a variety of sources, with differing amino acid sequence identity have been found to 
retain the necessary sequence required to form the binding site, for enzyme and protein 
binding [100].  For the isolated caldesmon-CaM complex a clear band was seen at ~90 
kDa for the caldesmon protein and a second band at ~42 kDa for the CaM-TEV-DsRed-
Monomer fusion.  A further band seen at ~70 kDa is believed to represent a low 
molecular weight form of caldesmon [101, 102], also extracted from the chicken 
gizzards.  In order to verify the identity of the caldesmon protein a dot blot assay was 
done, using the same protocol as for the CaM-M13-DsRed-Monomer complex.  The dot 
blot, with the anti-caldesmon primary antibody, clearly showed the presence of 
caldesmon in the eluted protein complex (Figure 27).  Again this dot blot was compared 
to the flow through from the initial wash of the column to determine if any of the 
caldesmon was being washed off before its elution with CaM-TEV-DsRed-Monomer.  
Utilizing the same anti-caldesmon primary antibody, the caldesmon-CaM-TEV-DsRed-
Monomer complex was examined by western-blotting (Figure 28).  This western-blotting 
showed only a single band, representing the high molecular weight caldesmon.    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Figure 25:  SDS-PAGE gel of crude caldesmon extracted from chicken gizzards (lane 2), 
molecular weight protein marker (lane 1) 
 
Figure 26:  SDS-PAGE gel of isolated caldesmon-CaM-TEV-DsRed-Monomer complex 
(lane 2), molecular weight protein marker (lane 1)  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Figure 27:  Dot blot assay of isolated caldesmon-CaM-TEV-DsRed-Monomer complex 
(left panel), collected flow through from the initial wash steps (right panel)  
 
 
Figure 28:  Western-blot of caldesmon-CaM-TEV-DsRed-Monomer    To identify this second band (~70 kDa) as a low molecular weight caldesmon, 
rather than a second calmodulin-binding protein, additional western-blotting studies are 
currently underway in our laboratory.  Furthermore, as demonstrated in the previous 
chapter, the TEV cleavage site, coded between the CaM and DsRed-Monomer, could be 
utilized to separate the caldesmon-CaM complex from the DsRed-Monomer, for 
additional studies. 
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4.4 Conclusion 
 
 The work presented in this chapter demonstrates a proof-of-concept use of 
DsRed-Monomer, to isolate a protein-protein or protein-peptide complex.  Two 
representative complexes were chosen for these studies, CaM-M13 and caldesmon-CaM.  
While both of these interactions are well understood, we envision that the method 
described here could be used to isolate unknown binding partners from a crude cellular 
matrix as well as for in vivo studies.  The studies presented here address a number of 
problems identified for other isolation/purification tags, such as the expense and stability 
of antibodies for immunoaffinity, or the multiple tags required for TAP.  DsRed-
Monomer tags have been demonstrated here and in previous work to have no effect on 
protein expression, or folding, allowing their use in native environments.  The natural 
copper-binding affinity of this protein also allows for a simple, one-step, purification on 
an inexpensive metal-affinity column.  The fluorescence of DsRed-Monomer can also be 
utilized for tracking protein-protein complexes in vivo, for future studies.  Additionally, 
the natural red color of the DsRed-Monomer protein, simplifies this purification, 
allowing the eluted complex to be visually observed during the purification.   
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CHAPTER 5.  RED FLUORESCENT PROTEIN VARIANTS WITH INCORPORATED 
NON-NATURAL AMINO ACID ANALOGUES 
 
 
5.1 Introduction 
 
The discovery and mutation of DsRed has expanded the possible uses of 
fluorescent proteins beyond those demonstrated for the more commonly used GFP.  
While the bulk of the genetic modifications performed on DsRed, have been aimed at 
improving the many limitations observed for native DsRed [3, 4, 8, 12, 103, 104], as 
discussed in Chapter 1, recent studies have focused on the possibility of expanding the 
color pallet of its fluorescence.  To date a few traditional mutagenesis studies have been 
done with DsRed and its variant, to shift the fluorescence excitation and emission 
wavelengths.  Such studies have primarily focused on the amino acid residues in and 
around the chromophore of the protein.  The chromophore of DsRed, as described in 
Chapter 1 of this work, is made up of a tri-peptide sequence of amino acids, specifically 
Gln-Tyr-Gly (residues 66-68) [7].  These residues form a fluorescently active 
chromophore autocatalytically through a three-step process, a cyclization reaction 
followed by two sequential dehydrogenations [26, 105].  The cyclization and initial 
dehydrogenation lead to a green emitting chromophore [106], this is shifted to a red 
emitting chromophore by the second dehydrogenation reaction.  This second 
dehydrogenation extends the conjugated π-system of the chromophore which creates the 
red fluorescence [107].  Here we describe exploratory studies in the construction and 
characterization of variants of DsRed-Monomer with altered spectral properties by 
incorporating non-natural amino acids into the protein.   
Rational mutagenesis has, so far, been a choice method to create variants of 
proteins with altered properties and to study structure-function relationships [3, 104].  In 
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this method, canonical amino acids are inserted into specific positions within the protein.  
For example, site-directed mutagenesis performed on mRFP1 resulted in the creation of 
variants with shifted excitation and emission wavelength maxima of up to 18 nm.  These 
shifts have been attributed to altered electrostatic interactions with the chromophore of 
the protein [108].  However, incorporation of non-natural amino acids offers an 
alternative method, allowing for the addition of novel functional groups into proteins 
[104, 109-112].  For example, site-specific incorporation of non-natural amino acids has 
been used to create mutants of GFP [113-116], which show a variety of fluorescence 
shifts and properties.  Specifically, incorporation of Trp analogues into GFP using a 
method of forced biosynthetic incorporation, has produced a number of “gold”-shifted 
fluorescent proteins [114].  In addition mutations at the Tyr66 position within the 
chromophore of GFP created mutants with no fluorescence or blue-shifted emission 
maximum depending on the analogue [115, 116].  Further incorporation of aromatic 
natural and non-natural amino acids into this same Tyr66 residue, of GFP, has shown a 
variety of emission shifts [115].  The fluorescence shifts observed for these mutants 
suggest the possibility of obtaining alternative, and biochemically appropriate fluorescent 
proteins by incorporating non-natural amino acid analogues into DsRed-Monomer. 
Although incorporation of non-natural amino acids has been successfully 
demonstrated in GFP [117], prior to the work presented here, such studies had not 
previously been done on DsRed, its mutants, or any red fluorescent proteins.  In this 
chapter we describe the incorporation of two Tyr analogues into DsRed-Monomer, 
creating variants with non-natural amino acid residues within the chromophore of the 
protein.  The position of the Tyr67 residue, as part of the DsRed chromophore, prompted 
the use of tyrosine analogues in our study to shift the fluorescence of the protein.  The 
non-natural amino acid analogues were incorporated into the protein by a system of 
forced biosynthetic incorporation [118], a simpler and quicker method than tRNA-based 
site-specific genetic incorporation.  This method relies on the use of a minimal media, 
starved of the amino acid targeted for incorporation.  The amino acid analogue of choice 
is added upon induction of the protein, allowing only the non-natural amino acid 
analogue to be incorporated into the final protein, in place of the native amino acid.  
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Hyun Bae et al. [114] showed that forced biosynthetic incorporation could be used for the 
overall incorporation of amino acid analogues into GFP.  However, further studies 
showed that incorporation of non-natural amino acids into any position, outside of the 
chromophore had no effect on the spectral properties of GFP [114].  On the basis of this 
we selected fluoro- and amino- analogues of tyrosine for our study, specifically 3-fluoro-
L-tyrosine and 3-amino-L-tyrosine [6].  Furthermore, X-ray crystal structure studies of 
DsRed has shown that the other Tyr residues within the protein do not interact with the 
chromophore and therefore should not affect the spectral properties of the protein [6].  
The fluoro- analogue was selected due to its significantly different pKa than the hydroxy 
functional group.  This has previously been used to alter the pKa of functional groups 
within the active site of enzymes, changing their catalytic properties [118, 119].  The 
addition of fluorinated amino acid analogues has also been found to affect the 
conjugation of the π-system of the chromophore and to cause limited changes in the bond 
lengths within such systems.  In addition, this analogue may promote the formation of 
additional hydrogen bonds within the system [118, 119].  In contrast, the amino- group, 
on the 3-amino-L-tyrosine, should primarily affect the electrostatic charge within the 
aromatic ring of the tyrosine and allow either a different pattern of hydrogen bonding 
with surrounding amino acid residues, or contribute to the conjugation of the 
chromophore.  The study here demonstrates that incorporation of non-natural amino acid 
analogues into DsRed-Monomer is a viable approach to alter the spectral characteristics 
of the protein.  We envision that this study will open up the door to non-natural amino 
acid incorporation studies with red fluorescent proteins and its mutants. 
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5.2 Materials and Methods 
 
5.2.1 Expression and Purification of DsRed-Monomer with Incorporated Non-Natural 
Amino Acids 
 
 The gene for DsRed-Monomer was digested with BamHI and EcoRI and cloned 
into pRSetB to construct the plasmid pSKD1, as previously described.  M9 minimal 
media [120, 121] containing 100 µg mL-1 ampicillin was prepared without tyrosine, 
tryptophan and phenylalanine.  A 5 mL sample of the minimal media was inoculated with 
E. coli, JM107, containing the plasmid pSKD1 and incubated overnight in a shaker at 37 
°C.  The culture was transferred to a 200 mL sample of the minimal media and grown to 
an OD420 of 1.00 and induced with isopropyl-β-D-thiogalactoside (IPTG, 0.5 mM final 
concentration, from Sigma).  Tryptophan, phenylalanine, and either tyrosine or the 
appropriate tyrosine analogue (1 mM final concentration of each amino acid, from 
Spectrum Chemicals) [118] was also added at that time.  The cultures were grown for a 
further 5 h with shaking, 250 r.p.m., at 37 °C and collected by centrifugation, 4000 
r.p.m., for 30 min at 4 °C.  The pellet was dissolved in the PBS-binding buffer (100 mM 
Na2PO3, 50 mM NaCl, pH 7.0) and sonicated for 5 min to lyse the cells.  The crude 
native DsRed-Monomer and the non-natural variants were purified on an immobilized 
copper charged sepharose column, as described in the previous chapter [16].  
 
5.2.2 Determination of Protein Purity and Concentration 
 
 Protein purity was determined by running an SDS-PAGE assay with 12.5 % 
acrylamide gel at 150 V for 90 min at room temperature.  Coomassie Brilliant Blue R-
250 solution was used to stain the gels overnight and destained for at least 2 h.  Protein 
concentration was determined by Bradford assay. 
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5.2.3 Spectral Analysis of Purified DsRed-Monomer with Incorporated Non-Natural 
Amino Acid and Comparison with Native DsRed-Monomer 
 
 Mass spectrometry analysis was performed by following the protocol of Gross et 
al. [5].  Approximately 2 nmol of purified protein was lyophilized and dissolved in 15 µL 
of sterilized water, 3 µL of guanidinium chloride (6 M) was added and the solution 
heated to 80 °C until it turned yellow.  The solution was cooled to room temperature and 
1 µL of HCl (0.33 M) was added followed by 10 µL of LysC endoprotease (0.05 µg/µL 
in 100 mM Tris, pH 9.2).  The digestion proceeded for 22 h at 37 °C and was quenched 
with trifluoroacetic acid (0.1 % vol/vol).  The mass spectra of each of the digested 
proteins were recorded on an Agilent 1100 Series LC/MSD, from Agilent Technologies 
(Santa Clara, CA) by direct injection, passing through the LC column 
 To obtain the fluorescence spectra, a volume of 200 µL (0.1 µM) of each of the 
non-natural mutants and the native DsRed-Monomer was placed into a microtiter plate, 
and excitation and emission scans of the proteins collected, using a Cary Eclipse 
Fluorescence Microtiter Plate Reader (Varian Inc, Walnut Creek, CA). 
 The UV-visible spectra were also collected.  A volume of 1 mL (0.1 µM) of the 
two mutants and the native DsRed-Monomer was placed in a cuvette, and the absorption 
spectra recorded at room temperature, using an Agilent 8453 UV-visible spectrometer 
(Agilent Technologies, Santa Clara, CA) 
 The CD spectra of the proteins were also collected.  The purified non-natural 
mutants and the native protein (250 µL, 0.1 µM) were placed in a 0.2 cm cell, and the 
adsorption spectrum was obtained at room temperature, using a Jasco Corporation 
spectropolarimeter (Tokyo, Japan). 
 Temperature and pH stability was also evaluated.  Fluorescence spectra were 
recorded at 4 °C, room temperature (25 °C) and 37 °C for both the native protein and the 
two variants.  Each protein was incubated for at least 2 h, at their respective temperature, 
prior to their spectra being collected.  The pH of the proteins was adjusted from 4 to 11, 
with MOPS buffer, in increments of 1 pH unit, and the fluorescence emission of each 
protein recorded.    
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5.3 Results and Discussion 
 
 Fluorescent protein variants with differing spectral characteristics are highly 
desirable for biotechnology and cell biology studies.  To obtain these variants a number 
of approaches including random mutagenesis, directed evolution, and non-natural 
mutagenesis have been successfully used.  Previously in these studies GFP was primarily 
used as the scaffold.  The availability of the red fluorescent protein, DsRed, provides a 
unique opportunity to further extend the spectral diversity of FPs.  Thus far only 
mutagenesis of naturally available amino acids has been attempted with DsRed.  Here we 
studied incorporation of non-natural amino acid analogues into DsRed-Monomer, to 
construct variants that yield alterations in the spectral characteristics of the protein.  In 
our study, DsRed-Monomer and its variants with non-natural amino acids were expressed 
in minimal media using a method of forced biosynthetic incorporation.  For this method 
the non-natural analogue was added to the culture media at a stage right before the 
protein expression.  This method was chosen, for this study, rather than directed 
incorporation of non-natural amino acids because the latter method is complicated and 
time consuming, and the aim of this study was an initial demonstration of amenability of 
DsRed to non-natural mutagenesis. 
 The plasmid pSKD1 was transformed into E. coli cells and the proteins were 
expressed.  During expression the time for the initial observation of color and the time to 
reach maximum fluorescence for the mutants were comparable to native DsRed-
Monomer, in the minimal media.  This indicates no change in the folding ability of the 
proteins upon mutation.  Furthermore, we did not observe any formation of protein 
aggregates in the mutants as well as in the native DsRed-Monomer, implying no effect on 
the solubility of the proteins.  The proteins were purified using an immobilized copper 
column, as previously discussed [16].  The purified proteins were run on an SDS-PAGE 
gel to verify purity (Figure 29).  The non-natural variants of DsRed-Monomer were 
analyzed by spectroscopic and spectrometry techniques, and their characteristics were 
compared to those of native DsRed-Monomer prepared in the same manner.  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Figure 29:  SDS-PAGE gel of crude (left panel) and purified (right panel) non-natural 
analogues of DsRed-Monomer.  Molecular weight protein marker (lane 1 and 5), crude 
DsRed-Monomer (lane 2), crude 3-amino-L-tyrosine variant (lane 3), crude 3-fluoro-L-
tyrosine variant (lane 4), pure DsRed-Monomer (lane 6), pure 3-amino-L-tyrosine variant 
(lane 7), and pure 3-fluoro-L-tyrosine variant (lane 8)    To verify the incorporation of the non-natural analogues into the chromophore of 
the protein, the mass spectra were collected for the DsRed-Monomer and for the non-
natural mutants. The proteins were subjected to LysC digestion, which produced a 
peptide that included the chromophore of the protein, of mass 2185 for the native DsRed-
Monomer [5].  The spectra of the non-natural variants showed the expected increases in 
mass, compared to the native protein (Table 9).  A mass increase of approximately 15 
was seen for the peptide of the amino- mutant compared to the chromophoric peptide 
obtained from the native protein.  This increase coincides with the addition of an amino- 
group onto the aromatic ring of tyrosine, within the chromophore.  The fluoro- mutant 
showed a mass increase of approximately 18 compared with the native protein, 
corresponding to the addition of fluorine onto the tyrosine ring.  This mass analysis 
confirms the presence of non-natural amino acid analogues into the peptide forming the 
chromophore.  Furthermore, the mass spectra of the mutants did not show any peak 
corresponding to the native DsRed-Monomer, suggesting the full incorporation of the 
non-natural analogues into the protein. 
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Table 9:  Characteristics of DsRed-Monomer and its non-natural variants   λexcitation (nm)   λemission (nm)   ε  (M‐1cm‐1)   Quantum Yield (%)  Mass of Chromophore peptide DsRed‐Monomer  556  603  59,000  0.04  2185 Amino‐ Variant  556  615  59,000  0.20  2199.6 Fluoro‐ Variant  556  591  47,000  0.13  2205    The fluorescence excitation and emission spectra of both the purified DsRed-
Monomer and the purified non-natural mutants were recorded.  The incorporated 
analogues showed no effect on the excitation spectra of the proteins, with the expected 
excitation maxima of 556 nm seen for each of the mutants.  However, variations in peak 
intensity were seen, the amino- mutant showed the strongest fluorescence excitation 
intensity, with the fluoro- mutant intermediate, and native DsRed-Monomer the weakest.  
Spectral shifts, however, were observed in the emission spectra.  The fluoro-tyrosine 
incorporated mutant showed a distinct blue shift of 12 nm (λmax 591 nm) compared to 
native DsRed-Monomer (λmax 603 nm), whereas the amino-tyrosine incorporated mutant 
showed a red shift of 12 nm (λmax 615 nm) (Figure 30).  These opposite shifts in emission 
wavelength maximum were expected since the two analogues would have opposite 
effects on the conjugated electron system of the chromophore.  The addition of the 
amino- group will lead to a more expanded π-conjugated chromophore system [116], at 
the aromatic ring, because of the electron donation of this group.  We expected that this 
would stabilize the conjugation in the chromophore leading to the observed red shift in 
the emission spectra.  The fluoro- addition, however, would withdraw electrons from the 
conjugated system of the aromatic ring and chromophore in general.  This reduction in 
the aromaticity of the Tyr phenyl ring may cause destabilization of the conjugation 
leading to the observed blue shift in emission.  The absence of any secondary peaks or 
shoulders indicates 100 % incorporation of the non-natural amino acid of interest into the 
protein occurred.  Any partial incorporation could have also given peaks or shoulder 
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similar to the native protein, which, were not observed.  These results were obtained from 
a number of different expressions, and demonstrate the reproducibility of these 
observations.  Emission spectra were recorded using the same concentration of all three 
proteins (data not shown); these spectra showed that the amino- mutant gave the most 
intense fluorescence followed by the fluoro- mutant and native DsRed-Monomer giving 
the lowest intensity emission at their respective emission wavelength maxima.  Further 
studies showed that temperature insensitivity (between 4 and 37 °C) of the protein’s 
fluorescence was maintained for the mutants compared with native DsRed-Monomer.  
The pH dependence of the fluorescence intensity of native DsRed-Monomer, the amino- 
and fluoro- variant was studied.  The fluorescence intensity was found to be unaffected 
between pH 5 and 11.  This is consistent with the results obtained by Baird et al. [3] that 
showed negligible dependence of DsRed-Monomer’s fluorescence intensity on pH. 
 
 
Figure 30:  Normalized fluorescence emission spectra of DsRed-Monomer and non-
natural mutants.  (■) native DsRed-Monomer, (▲) 3-amino-L-tyrosine DsRed variant, 
(Δ) 3-fluoro-L-tyrosine DsRed variant 
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The UV-Visible spectra of the purified DsRed-Monomer and the purified non-
natural mutants were recorded from 400 to 650 nm to further explore the spectral 
properties of these mutants.  It has previously been reported [4, 122] that the UV 
absorption spectra of a monomeric DsRed, mRFP1, showed a strong peak at 556 nm 
corresponding to the red fluorescent species.  The spectra also showed two additional 
peaks at ~480 and ~520 nm [1].  The peak at 480 nm has previously been attributed to a 
green-emitting intermediate for native (oligomerized) DsRed [3, 106].  The UV-visible 
spectra of DsRed-Monomer and the non-natural mutants (Figure 31) showed that the 
chromophore of all the proteins was absorbed strongly at the expected 556 nm and 
showed two additional peaks at 480 and 520 nm.  An excitation study performed at 480 
nm yielded only minimal fluorescence, on the order of 20 % of that seen at 603 nm.  The 
same pattern of peaks was seen for all three proteins; however, the intensity of the 
absorbance peaks varied.  Of the three proteins, the fluoro- variant showed the most 
pronounced peak at 480 nm.  Within the spectra of the fluoro- mutant, the peak at 480 nm 
appeared more intense than the peak at 556 nm corresponding to the red fluorescent 
species.  This suggests that incorporation of the fluoro- group may hinder the conjugation 
necessary for the red chromophore formation, locking the chromophore at an 
intermediate stage.  This also may account for the decrease in fluorescence emission, 
seen for this protein compared to the amino- mutant.  The amino- mutant showed the 
most pronounced peak at 556 nm, corresponding to emission from the major red 
fluorescent species.  The 556 nm peak of the amino- mutant was also of highest 
absorbance units among the three proteins. This coincides with the fluorescence emission 
spectra of the proteins in which the amino- mutant showed the most intense fluorescence 
emission.  This variant also showed an absorbance intermediate to both native DsRed-
Monomer and the fluoro- variant, at 480 nm.  The native DsRed-Monomer showed the 
lowered absorbance at both 480 and 556 nm; however the shoulder at 520 nm was more 
pronounced for this protein than for either of the variants.  This shoulder was almost 
undetectable for the two variants.  These fluorescence and absorbance observations 
further indicate that the position and electron density on Tyr67 are crucial for red 
chromophore formation in addition to the amino acids (Gln66 and Gly68) necessary for 
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the extended conjugation observed in DsRed.  Further, Tyr67 can potentially be targeted 
to generate variants with far red-shifted emission wavelengths.  
 
Figure 31:  UV-Visible absorption spectra of DsRed-Monomer and non-natural mutants.  
(■) native DsRed-Monomer, (▲) 3-amino-L-tyrosine DsRed variant, (Δ) 3-fluoro-L-
tyrosine DsRed variant    From the UV and fluorescence data, the extinction coefficients and quantum 
yields of DsRed-Monomer and each of the mutants were determined (Table 9).  The 
quantum yield for all three proteins was calculated using DsRed-Express with a known 
quantum yield as the standard and by using the following equation [123]: 
 
Q = QR (I/IR)(ODR/OD)(n2/nR2) 
 
where Q represents the quantum yield, I the intensity of the fluorescence, OD the optical 
density and n the refractive index.  The values with subscript R correspond to the 
reference protein, DsRed-Express.  This protein was chosen as the reference because it is 
the tetrameric form of DsRed-Monomer.  For DsRed-Monomer, a surprisingly low 
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quantum yield of 0.05 was calculated.  The quantum yield of the two variants appeared to 
be closer to the value of 0.4 reported for DsRed-Express.  The quantum yields calculated 
here show that the variants obtained have improved brightness compared with the native 
DsRed-Monomer.  This is an interesting observation since increases in quantum yield is 
obtained for both the amino- and fluoro- variants.  This indicates that this increase is not 
due specifically to the presence of the fluoro- or amino- group on the Tyr.  The quantum 
yield of DsRed-Monomer compared with DsRed-Express [4] is significantly lower.  This 
has previously been attributed to the loss of shielding of the chromophore in the 
monomer.  Therefore, we speculate that the presence of the amino- or fluoro- group on 
the Tyr ring, increasing the bulkiness of the Tyr, may improve this shielding of the 
chromophore in the mutated DsRed-Monomer, leading to the improved quantum yield 
observed here.  
 The far UV CD spectra of the native DsRed-Monomer and the non-natural 
variants were also recorded (Figure 32).  This information was submitted for k2D 
analysis.  These spectra showed that the overall secondary structural characteristics of the 
protein were maintained after the incorporation of the tyrosine analogues. 
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Figure 32:  CD spectra of DsRed-Monomer and non-natural mutants.  (■) native DsRed-
Monomer, (▲) 3-amino-L-tyrosine DsRed variant, (Δ) 3-fluoro-L-tyrosine DsRed 
variant.  Some data sets are not visible due to the exact overlap of all data points 
 
 
5.4 Conclusion 
 
 The incorporation of non-natural amino acid residues into the chromophore of 
DsRed-Monomer caused a shift in the fluorescence emission.  The fluoro- variant showed 
a 12 nm blue shift and the amino- variant a 12 nm red shift in fluorescence emission.  The 
incorporation of these tyrosine analogues was verified by mass analysis of the peptide 
containing the chromophore.  These variants also displayed improvements in their 
quantum yields and fluorescence emission intensities, compared to the native DsRed-
Monomer.  In addition, the absorption spectra of all three showed the same pattern of 
peaks, with variations in their relative intensities.  The incorporation of the tyrosine 
analogues into the chromophore of DsRed-Monomer appears to have no effect on the 
overall structure of the variants.  The studies performed by us demonstrate that the 
spectral properties of red fluorescent proteins can be altered by non-natural mutagenesis.  
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The variants produced in our study can be purified and used as labels for in vitro 
multicolor applications.  Furthermore, the studies performed show that the Tyr in the 
chromophore, of DsRed-Monomer, can be manipulated to produce variants with unique 
properties.  For in vivo applications, such variants can be produced using modified 
tRNAs that code for non-natural amino acids. 
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CHAPTER 6.  CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
6.1 Conclusions and Future Directions 
 
The work presented in this thesis has focused on the biochemical applications of a 
red fluorescent protein, DsRed-Monomer.  In this work both DsRed-Monomer’s natural 
fluorescence and its unique copper-binding affinity, which results in fluorescence 
quenching, have been exploited.  This unique metal-binding affinity has previously been 
utilized for the purification of DsRed-Monomer and in the development of copper 
sensing systems.  In this thesis work we have performed studies to identify the 
mechanism of this fluorescence quenching seen for DsRed-Monomer in the presence of 
copper.  Through a series of studies, as described in Chapter 2, which included 
determining the copper dissociation constant, spectroscopic studies in the presence and 
absence of copper, the effect of pH on this copper-binding affinity, and computational 
studies, we were able to shed light on the fluorescence quenching mechanism of DsRed-
Monomer and hypothesized possible copper-binding residues within the protein.  These 
studies suggested that, upon copper-binding, a sphere of action static quenching 
mechanism results in the observed fluorescence quenching.  These studies, specifically 
the pH and computational studies, indicated the possible involvement of His and/or Cys 
residues in this copper-binding.  Further studies with this protein will be required to 
formally identify the copper-binding site of DsRed-Monomer and other RFP variants.  
Based on our studies within this chapter, two specific His residues, His25 and His216, 
could be targeted for future studies.  These studies will include site-directed mutagenesis 
and chemical modifications, which can be monitored by fluorescence quenching assay, to 
study their effect on the DsRed-Monomer’s copper-binding affinity.  The copper-binding 
site, once identified, can be subjected to further rational mutagenesis with the aim of 
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improving the copper-binding affinity constant for DsRed-Monomer, while retaining this 
unique copper specificity.  Such improvements of this affinity (KD), to nM levels, would 
allow for improved use of DsRed-Monomer as an affinity tag for isolation and 
purification, while retaining the ability to elute this tag under relatively mild conditions.  
By understanding this quenching mechanism and identifying the copper-binding site of 
DsRed-Monomer, we believe that improvements can be made in the copper-binding 
affinity.  Such improvements may enhance the utility of DsRed-Monomer as an affinity 
tag for purification and isolation assays as well as offering possible expansion to the uses 
of the fluorescence of this protein. 
Another work in this thesis focused on the use of DsRed-Monomer for both 
purification and detection of a fusion partner, exploiting the copper-binding affinity and 
the fluorescence of the protein.  We designed and created, via molecular biology 
techniques, an N-terminal fusion of DsRed-Monomer with a protein, calmodulin.  Using 
DsRed-Monomer’s natural copper-binding affinity we were able to purify this fusion 
partner, calmodulin, on an immobilized copper column.  The calmodulin fusion partner 
was then separated from the DsRed-Monomer tag, via proteolytic cleavage, of a TEV site 
encoded between calmodulin and the DsRed-Monomer tag.  Additionally, we used 
DsRed-Monomer’s fluorescence to design a detection assay for a calmodulin-binding 
ligand, chlorpromazine.  We observed a decrease in fluorescence emission with 
increasing concentrations of chlorpromazine.  We attributed this to the binding of 
chlorpromazine to calmodulin, causing a structural change in the calmodulin and 
subsequently the environment of the DsRed-Monomer, resulting in this decrease in the 
fluorescence emission.  We would like to continue to explore this type of DsRed-
Monomer fusion assay by expanding the selection of fusion partners.  Such work would 
utilize an additional set of fusion partners to explore this method to purify other target 
proteins.  We would also like to expand on the use of the fluorescence-based detection 
assay, of such DsRed-Monomer fusion proteins, by demonstrating the viability of 
developing further assays for studying target protein-ligand pair binding.  The use of this 
assay in a cellular environment is also of interest to the continuation of this work, since 
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the work to date has utilized a buffer matrix only.  For this work we would express 
DsRed-Monomer fusions in vivo where a target ligand is also present.  
 The aim of our next work was to utilize DsRed-Monomer’s natural copper-
binding affinity, in the design of an isolation tag, for interacting peptide-protein or 
protein-protein complexes.  This work utilized N-terminal fusions of DsRed-Monomer 
with either a peptide or protein bait partner.  One such fusion of DsRed-Monomer was 
designed, utilizing molecular biology, to fuse a peptide to the N-terminus of the DsRed-
Monomer protein.  For this work the M13 peptide from skeletal muscle myosin light 
chain kinase, a calmodulin-binding peptide, was selected as the fusion partner.  Initial 
studies with this fusion were done to demonstrate DsRed-Monomers use as an affinity tag 
to isolate a peptide-protein complex, calmodulin-M13, via copper-affinity purification.  
In this study DsRed-Monomer’s natural fluorescence was not specifically used in a 
detection sense, however, it did simplify the purification as the red band could be 
observed eluting off the column.  The previously discussed calmodulin-DsRed-Monomer 
fusion was also used in these studies to explore the use of a protein-DsRed-Monomer 
fusion as an affinity tag for isolating protein-protein complexes.  In this work we 
demonstrated isolation of a caldesmon-calmodulin complex, again using DsRed-
Monomer’s copper-affinity.  The current study has been performed using a cellular 
extract as a matrix; however, we can also employ DsRed-Monomer as an affinity tag to 
isolate protein-protein interacting complexes in an in vivo system.  In the future we 
envision using these, and other, DsRed-Monomer fusions to isolate unknown binding 
partners in in vivo studies.  Again such work will require expressing the DsRed-
Monomer-target protein fusions within cells, to which an interacting protein binds.  This 
complex once isolated, using the copper-based affinity of DsRed-Monomer, can be 
subjected to mass spectrometry analysis for identification of interacting proteins or 
ligands. 
 The final study in this thesis demonstrates the amenability of this protein to non-
natural mutagenesis.  These studies were aimed at increasing the color pallet of possible 
fluorescent reporters and tags.  Here we focused on the three amino acids residues, which 
form the internal chromophore of DsRed-Monomer.  Utilizing forced biochemical 
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incorporation we replaced the tyrosine residues within the sequence of DsRed-Monomer 
with either a fluoro- or amino- variant.  These non-natural variants of DsRed-Monomer 
were spectroscopically analyzed, showing a shift in the observed fluorescence emission.  
The fluoro- variant showed a 12 nm blue shift and the amino- variant showed a 12 nm red 
shift, compared to DsRed-Monomer expressed in the minimal media.  This work 
demonstrated the ability to shift the fluorescence emission, and other spectral 
characteristics, of DsRed-Monomer via non-natural mutagenesis.  We envision these 
variants being used in the future as reporter tags, such as those discussed in the previous 
chapters of this and in other works for native DsRed-Monomer.  Such reporters have 
been designed for both in vitro and in vivo studies.  We believe that non-natural variants 
of this, and other fluorescent proteins, will be efficient tools for such methods, as well as 
for two-color labeling studies.  Future non-natural mutagenesis studies will focus on the 
incorporation of additional non-natural Tyr analogues into the chromophore of the 
protein, as well as non-natural Gln and Gly analogues.  Additionally, we will explore the 
use of modified tRNAs for efficient, site-specific incorporation of non-natural amino 
acids into DsRed-Monomer. 
 Since it’s discovery DsRed and its variants have been utilized in a number of 
biochemical applications, the work presented in this thesis aims to expand these 
applications of one such variant, DsRed-Monomer.  The initial studies, described in this 
work, aimed at defining the mechanism of copper-induced fluorescence quenching will 
ideally lead to a better understanding and future improvements of this protein’s copper-
based fluorescence behavior and of the copper-affinity.  Further, we have explored 
biochemical applications for this protein, based upon both copper-binding affinity and 
fluorescence.  We have demonstrated the amenability of this protein to N-terminal fusion 
with both peptides and proteins, with no effect on its overall structure or spectroscopic 
properties.  Additionally, we have shown that DsRed-Monomer can serve as an affinity 
tag for efficient purification of target proteins, as a fluorescent reporter tag for interacting 
ligands, and as a tag to isolate interacting protein complexes.  We envision that these 
findings can be potentially expanded to various biochemical studies and applications. 
Furthermore, we believe that the expansion of the color pallet of DsRed-Monomer 
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demonstrated here by non-natural mutagenesis could be of great interest for future 
multicolor labeling studies. 
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Appendix A:  Creation of DsRed-Monomer 
 
The major problems associated with native DsRed have involved the 
intermediate/parasitic green fluorescence, low extinction coefficient, and the tendency for 
oligomerization.  The previous section of this chapter described how the former two have 
been addressed through directed evolution and site-directed mutagenesis.  However the 
problem of oligomerization presented more challenges.  The native DsRed protein is 
primarily negatively charged, with the exception of a short length at the N- terminal 
region which contains a group of positively charged amino acid residues.  This positively 
charged region was thought to be the most likely cause of the high molecular weight 
aggregates, primarily tetramers, seen with this protein [124].  It also appears to be 
possible for each tetramer to form up to four salt bridges with adjacent tetramers, forming 
stable polymeric structures.  Since the isolation of DsRed, a number of groups have 
attempted to resolve the problem of aggregation, the results of which will be discussed 
below.       
It has long been known that native DsRed formed extensive oligomers both in 
vitro and in vivo, however the exact behavior of the protein and degree of aggregation 
were not fully understood.  Baird et al. [3] explored this oligomerization of native DsRed 
by comparing SDS-PAGE gels of boiled and un-boiled samples of DsRed.  The un-boiled 
samples showed a band at >110 kDa, while after boiling this band was no longer seen.  
This suggested that an oligomerized form of the protein was present in the un-boiled 
sample.  This was further studied by analytical equilibrium centrifugation, which showed 
molecular weights corresponding to a tetrameric form of the protein.  To determine if this 
aggregation was seen in vivo, the oligomerization was further explored by a FRET study 
in mammalian cells and a two-hybrid assay in yeast.  Both of these confirmed that native 
DsRed forms a tetramer in vivo. 
The aggregation of native DsRed was reduced by Bevis et al. [124]  both in vivo 
and in vitro by decreasing the net positive charge at the N- terminal region of the protein.  
As previously observed, native DsRed is unusually basic.  These basic patches on the 
surface of the protein interact with acidic patches on a second unit of DsRed (or other 
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macromolecules) forming high order aggregates.  By eliminating the cluster of positive 
charges near the N- terminus through point mutations, these interactions can be 
minimized.  A decrease in the strength of these oligomeric interactions was observed 
upon mutation; however complete elimination of aggregation was not achieved. 
The first commercially available non-aggregating mutant of DsRed was generated 
by Yanushevich et al. [8].  This group focused on minimizing the aggregation of a 
number of fluorescent proteins, including three DsRed mutants; E57 [9], E5 [10] and 
ds/drFP616 [11].  Following the example of Bevis’ and Baird’s groups [3, 124], this work 
focused on the fully charged N- terminal residues.  A series of mutants of E57, containing 
R2A, K5E, and K9T substitutions in different combinations were created.  Of these 
mutations, R2A appeared to have the strongest impact on the overall aggregation of the 
proteins.  One mutant, E57-NA, with all three mutations, showed no aggregation.  This 
mutant also showed spectroscopic properties similar to E57; with similar maturation time, 
brightness of colonies, and excitation/emission wavelength maxima.  This mutant was the 
first commercially available monomer of DsRed, specifically called DsRed2.  These 
mutations were generated for both E5 and ds/drFP616 with similar results, creating 
mutants which appear to be monomeric on SDS-PAGE gels.  Additionally these mutants 
appeared to retain the spectral properties of the respective parent mutant, E5 and 
ds/drFP616.  
An improved monomeric DsRed was generated by Campbell et al. [4].  Initially a 
dimer of DsRed was prepared by a single point mutation, I125R.  This mutant gave poor 
red fluorescence with an increased green component and a much longer maturation time.  
To improve the fluorescence of this dimer directed evolution was used to identify 
mutants with the desired properties.  Dimer2, with 16 additional mutations, was isolated 
from this pool of mutants.  Of the 17 mutations present in the final dimer, eight are 
internal to the β-barrel, three are aggregation reducing R2A, K5E, and N6D, two are at 
the AB interface of two single units I125R, V127T, and the final four are surface 
mutations.  Using this dimer2, a tandem dimer, tdimer2 [125], was generated.  A 
polypeptide linker was used to attach two dimer2 units, such that critical dimer 
interactions were satisfied by this tandem linker.  Linkers of 9, 12, 13, or 22 amino acid 
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residues were used to form these tandem dimers.  All of these tandem dimers, showed 
essentially the same behavior except the clone with the 9 residue linker, which was 
slower to mature.  The tandem dimer with the 12 residue linker, tdimer2 [125], was 
chosen for further study.  This tandem dimer showed excitation and emission wavelength 
maxima identical to that of dimer2, with an extinction coefficient twice that of dimer2, 
due to the presence of the two absorbing chromophores per polypeptide chain.  tdimer2 
[125] became the focus of forming a true DsRed monomer.  By a series of directed 
evolution steps targeting H162 and A164 of the tandem dimer a first generation 
monomer, mRFP0.1, was identified.  This monomer was further mutated, by directed 
evolution, through six generations yielding mRFP1, with a total of 33 amino acid 
substitutions, relative to DsRed.  Of these substitutions 13 are internal to the β-barrel, 
three are aggregation reducing mutants R2A, K5E, and N6D, three are AB interface 
mutations I125R, V127T and I180T, ten are AC interface mutations R153E, H162K, 
A164R, L174D, Y192A, Y194K, H222S, L223T, F224G, and L225A, and the remaining 
four are non-specific beneficial mutations.  Both the dimers and monomers generated by 
this group appear to overcome the major problem, which previously prevented the 
formation of a stable non-aggregating form of DsRed.  Decreasing the charge of the N- 
terminal region of the protein had the greatest effect on the protein’s aggregation and 
oligomerization. 
Shaner et al. [12] reported a further improvement in mRFP1 [4].  mRFP1 was 
subjected to many rounds of directed evolution, the resulting colonies were screened both 
manually and by fluorescence-activated cell sorting (FACS)-based screening.  This 
screening isolated many mutants with differing emission maxima, increased tolerance to 
N- and C- terminal fusions, improved extinction coefficients, higher quantum yields, and 
high photostability.  However none of these mutants showed improvements in all of these 
properties.  A second approach was examined by substituting residues around the 
chromophore of the protein, Gln66, Tyr67, and Gly68.  One clone from this library, 
mRFP1.1, with a Q66M substitution, showed a minor fluorescence shift of 5 nm, in both 
excitation and emission, and more complete maturation.  This mutant was further 
modified, to reduce its sensitivity to the N- terminal fusion, by replacing the first seven 
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amino acid residues with the corresponding residues from enhanced GFP, MVSKGEE 
followed by a spacer, consisting of residues NNMA (6a-6d).  Additionally the last seven 
residues at the C- terminus were also appended to that of GFP, creating mRFP1.3.  This 
fluorescent mutant of mRFP1 was not affected by the N- terminal fusion.  The clone 
mRFP1.4 was generated by the addition of two more point mutations, V7I and M182K, 
which showed improved folding of the protein’s chromophore.  An additional 
substitution of M163Q resulted in a complete loss of green fluorescence.  The final 
optimized monomer, mCherry, included the additional mutations R17H, T195V, D196N, 
and N6aD.  Further mutations, at the 66 position of both mRFP1.1 and mRFP1.4, along 
with additional rounds of directed evolution, yielded a series of fluorescently shifted 
mutants: mTangerine, mHoneydew, mOrange, and mStrawberry.  Each of these 
monomers showed an improvement in a specific area of fluorescent protein research, 
offering an improved quantum yield, extinction coefficient, or fluorescence intensity; 
however mCherry is the most promising overall.  The fluorescence excitation and 
emission wavelength maximum of mCherry showed a significant red shift to 587 nm and 
610 nm, respectively.   This mutant also showed shorter maturation times than native 
DsRed and mRFP1.  However mCherry showed quantum yields, extinction coefficients, 
and brightness of colonies comparable to mRFP1.  Through directed evolution on the 
dimer, dimer2 [4], a promising new dimer mutant, dTomato, was generated.  The 
dTomato mutant showed higher tolerance to N- and C- terminal fusion, as seen for 
mCherry.  Since tandem dimers of DsRed reduced its oligomerization [4], a tandem 
dimer, tdTomato, was generated from the dTomato mutant.  Both dTomato and tdTomato 
showed improved maturation kinetics.  Additionally, both showed limited parasitic green 
fluorescence and a minor red shift in excitation and emission wavelength maxima to 554 
nm and 581 nm.  
A DsRed monomer is now commercially available from Clontech, denoted as 
DsRed-Monomer.  This monomer contains 45 amino acid substitutions in native DsRed.  
This protein overcame the oligomerization seen with native DsRed, which has been 
confirmed by a number of methods including gel filtration chromatography that showed a 
single uniform peak.  The retention time obtained for this peak is consistent with a 28 
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kDa molecular weight.  The spectral and maturation properties of this protein are 
comparable to those of the commercially available tetrameric DsRed, DsRed-Express, 
also from Clontech.  This protein displays a fluorescence excitation and emission 
wavelength maxima of 556 nm and 586 nm respectively. 
The DsRed monomers generated by both directed evolution and site-specific 
mutagenesis of amino acid residues have an ideal set of properties for biological and 
analytical applications.  The high quantum yields and extinction coefficients of these 
monomers have allowed for further uses of this protein to be explored and developed.  
Additionally the faster maturation and lack of oligomerization seen with these monomers 
should be an advantage for their use as fusion tags.  
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Appendix B:  Derivation of Dissociation Constant Equation  
 
The equilibrium constant for dissociation is a function of the ratios of the 
dissociation and association rates, kon and koff.  kon is often limited only by diffusion, so 
koff is the discriminator for differential binding.  KD can be measured if the concentration 
of the protein-ligand complex ([PD]) and either the free concentration of the protein ([P]) 
or the ligand ([D]) can be measured experimentally, for example through titration.  In 
practice [PD] is rarely measured, rather a spectroscopic change, such as fluorescence, 
upon binding of ligand to protein is measured. 
 
• KD =  = 
€ 
koff
kon
    
Bound fraction of protein/ligand, from conservation of mass 
[P] = [PT] – [PD] 
[D] = [DT] – [PD] 
• KD = 
€ 
([PT ]− [PD])([DT ]− [PD])
[PD]   
• 0 = [PT][DT] – (KD + [DT] + [PT]) [PD] + [PD]2 
• [PD] = 
€ 
(KD + [DT ]+ [PT ]) − (KD + [DT ]+ [PT ])2 − 4[DT ][PT ]
2  
 FP – Signal from free protein 
 FPD – Signal from the complex 
 F – Total fluorescence signal 
• F = FP[P] + FPD [PD] 
• F = Fp([PT] – [PD]) + FPD [PD] 
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• F = FP (1 – ) + FPD  
• F = FP  – FP  + FPD  
• F = FP + (FPD – FP)  
• F = FP + (FPD – FP)
€ 
(KD + [DT ]+ [PT ]) ± (KD + [DT ]+ [PT ])2 − 4[DT ][PT ]
2[PT ]
 
•  =  = 
€ 
(KD + [DT ]+ [PT ]) ± (KD + [DT ]+ [PT ])2 − 4[DT ][PT ]
2[PT ]
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